Cytta (CYCA) 10-K 14 Jan 25 2024 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Sep. 30, 2024	Jan. 14, 2025	Mar. 31, 2024
Cover [Abstract]
Entity Registrant Name	CYTTA CORP.
Entity Central Index Key	0001383088
Document Type	10-K
Amendment Flag	false
Entity Voluntary Filers	No
Current Fiscal Year End Date	--09-30
Entity Well Known Seasoned Issuer	No
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Sep. 30, 2024
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2024
Entity Common Stock Shares Outstanding		469,877,826
Entity Public Float			$ 10,325,640
Document Annual Report	true
Document Transition Report	false
Document Fin Stmt Error Correction Flag	false
Entity File Number	333-257458
Entity Incorporation State Country Code	NV
Entity Tax Identification Number	98-0505761
Entity Address Address Line 1	5450 W Sahara Ave Suite 300A
Entity Address City Or Town	Las Vegas
Entity Address State Or Province	NV
Entity Address Postal Zip Code	89146
City Area Code	702
Icfr Auditor Attestation Flag	false
Auditor Firm Id	273
Local Phone Number	900-7022
Security 12g Title	Common Stock, $0.001 par value
Entity Interactive Data Current	Yes
Auditor Name	Prager Metis CPAs, LLC
Auditor Location	Hackensack, New Jersey

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Sep. 30, 2024	Sep. 30, 2023
Current Assets
Cash	$ 1,439,835	$ 674,824
Prepaid expenses	544,046	986,976
Total Current Assets	1,983,881	1,661,800
Prepaid expenses, non-current	140,443	561,776
Property and equipment, net	50,867	77,558
TOTAL ASSETS	2,175,191	2,301,134
Current Liabilities
Accounts payable and accrued expenses	494,251	546,335
Related party liabilities	443,093	772,532
Dividend payable	33,427	33,427
Deferred revenue	2,914	2,411
Note payable	0	40,000
Convertible notes payable, net of discount	1,438,950	1,166,788
Total Current Liabilities an Total Liabilites	2,412,635	2,561,493
COMMITMENTS AND CONTINGENCIES	0	0
Stockholders' Deficit
Common stock par value $0.001; (600,000,000 shares authorized and 469,877,826 (September 30, 2024) and 426,831,170 (September 30, 2023) shares issued and outstanding)	469,879	426,832
Additional paid in capital	36,159,919	31,915,639
Accumulated Deficit	(36,867,892)	(32,603,480)
Total Stockholders' Deficit	(237,444)	(260,359)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	2,175,191	2,301,134
Series F Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	0	0
Series C Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	600	600
Series D Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	50	50
Series E Preferred Stock [Member]
Stockholders' Deficit
Preferred stock, value	$ 0	$ 0

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2024	Sep. 30, 2023
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	100,000,000	100,000,000
Common stock share, par value	$ 0.001	$ 0.001
Common stock share, authorized	600,000,000	600,000,000
Common stock share, issued	469,877,826	426,831,170
Common stock share, outstanding	469,877,826	426,831,170
Series F Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	10,000,000	10,000,000
Preferred stock share, issued	0	0
Preferred stock share, outstanding	0	0
Series C Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	12,000,000	12,000,000
Preferred stock share, issued	600,000	600,000
Preferred stock share, outstanding	600,000	600,000
Series D Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	10,000,000	10,000,000
Preferred stock share, issued	50,000	50,000
Preferred stock share, outstanding	50,000	50,000
Series E Preferred Stock [Member]
Preferred stock share, par value	$ 0.001	$ 0.001
Preferred stock share, authorized	13,650,000	13,650,000
Preferred stock share, issued	0	0
Preferred stock share, outstanding	0	0

STATEMENT OF OPERATIONS

STATEMENT OF OPERATIONS - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
STATEMENT OF OPERATIONS
Revenues	$ 4,492	$ 30,059
Operating Expenses:
General and administrative - related party	871,061	1,843,501
General and administrative - other	3,021,406	2,807,989
Total operating expenses	3,892,467	4,651,490
Loss from Operations	(3,887,975)	(4,621,431)
Other expenses (income)
Interest expense	376,959	107,192
Interest income	(522)	(150)
Total Other Expenses (Income)	376,437	107,042
Loss before income taxes	(4,264,412)	(4,728,473)
Provision for income taxes	0	0
Net loss	$ (4,264,412)	$ (4,728,473)
Loss per share, basic and diluted	$ (0.01)	$ (0.01)
Weighted average shares outstanding Basic and diluted	449,006,054	396,241,022

STATEMENT OF CHANGES IN STOCKHO

STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Preferred Stock Series C [Member]	Preferred Stock Series D [Member]
Balance, shares at Sep. 30, 2022		379,760,670			600,000	50,000
Balance, amount at Sep. 30, 2022	$ 461,792	$ 379,761	$ 27,956,388	$ (27,875,007)	$ 600	$ 50
Common stock and warrants issued for services, shares		41,575,000
Common stock and warrants issued for services, amount	2,175,819	$ 41,575	2,134,244	0	0	0
Common stock issued for accounts payable and accrued liabilities, shares		1,440,750
Common stock issued for accounts payable and accrued liabilities, amount	67,440	$ 1,441	65,999	0	0	0
Common stock issued for common stock payable, shares		54,750
Common stock issued for common stock payable, amount	54,750	$ 55	54,695	0	0	0
Options and warrants vested to purchase common stock	1,521,312	$ 0	1,521,312	0	0	0
Common stock and warrants issued for cash, shares		4,000,000
Common stock and warrants issued for cash, amount	100,000	$ 4,000	96,000	0	0	0
Warrants issued in conjunction with notes payable	87,001	0	87,001	0	0	0
Net loss	(4,728,473)	$ 0	0	(4,728,473)	$ 0	$ 0
Balance, shares at Sep. 30, 2023		426,831,170			600,000	50,000
Balance, amount at Sep. 30, 2023	(260,359)	$ 426,832	31,915,639	(32,603,480)	$ 600	$ 50
Common stock and warrants issued for services, shares		31,000,000
Common stock and warrants issued for services, amount	794,350	$ 31,000	763,350	0	0	0
Common stock issued for accounts payable and accrued liabilities, shares		9,046,656
Common stock issued for accounts payable and accrued liabilities, amount	239,643	$ 9,047	230,596	0	0	0
Options and warrants vested to purchase common stock	544,598	0	544,598	0	0	0
Net loss	(4,264,412)	$ 0	0	(4,264,412)	0	0
Common stock issued for accounts payable and accrued liabilities, related party, shares		3,000,000
Common stock issued for accounts payable and accrued liabilities, related party, amount	90,000	$ 3,000	87,000	0	0	0
Issuance of Reticulate Micro common stock for note convertible notes and accrued interest conversion	2,499,388	0	2,499,388	0	0	0
Warrants issued and vested to purchase Reticulate Micro common stock	119,348	$ 0	119,348	0	$ 0	$ 0
Balance, shares at Sep. 30, 2024		469,877,826			600,000	50,000
Balance, amount at Sep. 30, 2024	$ (237,444)	$ 469,879	$ 36,159,919	$ (36,867,892)	$ 600	$ 50

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (4,264,412)	$ (4,728,473)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expenses for services	1,967,989	3,136,341
Amortization of note discounts	48,211	38,790
(Gain) loss on debt extinguishment	(4,565)	20,171
Depreciation expense	41,397	45,432
Changes in Operating Assets and Liabilities:
Prepaid expenses	80,443	(49,282)
Accounts payable and accrued liabilities	292,245	69,718
Accounts payable-related party	24,457	29,594
Deferred revenue	503	2,411
Net cash used in operating activities	(1,813,732)	(1,435,298)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment	(14,707)	0
Net cash used in investing activities	(14,707)	0
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from stock subscriptions	0	100,000
Proceeds from issuance of note payable	0	40,000
Proceeds from issuance of short-term convertible notes payable	2,593,450	1,215,000
Net cash provided by financing activities	2,593,450	1,355,000
NET CHANGE IN CASH	765,011	(80,298)
CASH AT BEGINNING OF YEAR	674,824	755,122
CASH AT END OF YEAR	1,439,835	674,824
SUPPLEMENTAL CASH FLOW DISCLOSURES
Cash paid for interest	0	0
Cash paid for income taxes	0	0
NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued for services	794,350	2,175,819
Common stock issued for accounts payable and accrued liabilities	224,241	118,218
Common stock issued for accrued expenses, related party	108,250	55,393
Reticulate Micro common stock issued for convertible notes and accrued interest	$ 2,499,388	$ 0

Insider Trading Arragements

Insider Trading Arragements	12 Months Ended
	Sep. 30, 2024
Insider Trading Arragement [Line Items]
Rule 10b5-1 Arrangement Adopted [Flag]	false
Rule 10b5-1 Arrangement Terminated [Flag]	false
Non Rule 10b5-1 Arrangement Adopted [Flag]	false
Non Rule 10b5-1 Arrangement Terminated [Flag]	false

ORGANIZATION AND DESCRIPTION OF

ORGANIZATION AND DESCRIPTION OF BUSINESS	12 Months Ended
	Sep. 30, 2024
ORGANIZATION AND DESCRIPTION OF BUSINESS
ORGANIZATION AND DESCRIPTION OF BUSINESS	NOTE 1 - ORGANIZATION AND DESCRIPTION OF BUSINESS Cytta Corp., (“Cytta” or the “Company”) was incorporated on May 30, 2006, under the laws of the State of Nevada. It is located in Las Vegas, Nevada. Cytta is in the business of imagineering, developing and securing disruptive technologies.

GOING CONCERN

GOING CONCERN	12 Months Ended
	Sep. 30, 2024
GOING CONCERN
GOING CONCERN	NOTE 2 - GOING CONCERN The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. As of September 30, 2024, the Company had an accumulated deficit of $36,867,892 and has also generated losses since inception. These factors, among others, raise substantial doubt about the ability of the Company to continue as a going concern. The Company's proprietary CyttaCOMMS incident management software system offers real-time integration of video and audio streams, enabling improved collaboration and providing ongoing, relevant, actionable intelligence. Their innovative new product, CyttaCARES, is a game-changer in ensuring the safety and well-being of individuals in educational institutions and beyond. Cytta's CyttaCOMP ISTAR (Intelligence, Surveillance, Target Acquisition and Reconnaissance) technology delivers real-time compression of video streams with ultra-low latency, even in low bandwidth environments in conjunction with their compression Licensee Reticulate Micro, Inc. Cytta’s proprietary SUPR Intelligence, Surveillance and Reconnaissance (ISR) technology designated CyttaCOMP, is now licensed to Reticulate Micro, Inc. CyttaCOMP, is at the core of our products and is the most potent software compression codec commercially available. CyttaCOMP is explicitly designed for realtime streaming of HD, 4K, and higher resolution video while requiring only limited bandwidth and minimal computational resources. Cytta’s CyttaCOMMS (formerly IGAN Incident Command System (ICS) system) seamlessly streams and integrates all available video and audio sources during emergencies, enabling sharing of multiple video and audio inputs. The CyttaCOMMS product was introduced into the market in the last quarter of 2024. The CyttaCOMMS online software platform is fully SaaS based with no hardware components. The CyttaCOMMS introduces immediate real-time video and audio situational awareness, which is valuable for police, firefighters, first responders, emergency medical workers, industry, environmental and emergencies, security, military, and all their command centers in any emergency. The proprietary IGAN software technology powers, Cytta’s SaaS Based COMMS system creates an integrated communications platform which seamlessly streams all available video and audio sources in all critical situations, for first responders enabling real time event and interactive mapping information. Also based upon the IGAN technology, Cytta’s CyttaCARES (Crisis Alert and Response Emergency System) system is an innovative SAAS solution designed to enhance safety and security in educational institutions especially during emergency situations. This comprehensive system provides real-time alerts, rapid two-way secure video communication, and efficient response coordination with live location tracking to emergency response teams. We have created advanced video compression (SUPR), video/audio streaming and collaboration software (CyttaCOMMS), and school and institution safety and security software systems (CyttaCARES) that solve real world streaming, safety and security problems for multiple institutions and organizations. We believe our products will enable and empower the world to consume higher quality video anywhere, anytime while providing unparallelled safety and security. The Company intends to fund operations through equity and/or debt financing arrangements, which may not be sufficient to fund its capital expenditures, working capital and other cash requirements for the foreseeable future. During the year ended September 30, 2024, the Company issued $2,593,450 of convertible notes and in exchange for the note issuances received $2,593,450.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Sep. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying financial statements are prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“US GAAP”). Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at September 30, 2024, and 2023. Prepaid expenses The Company considers expenses or services paid for prior to the period the expense is completed to be recorded as a prepaid expense. Included in this account is the value of common stock, options and warrants issued to consultants. Such issuances are pursuant to consulting agreements that can have a one-to-two-year term. The Company amortized the value of the stock issued over the term of the agreement. The activity for the years ended September 30, 2024, and 2023 is summarized as: September 30, 2024 2023 Balance beginning of period $ 1,548,752 $ 32,897 Value of common stock issued 309,550 2,399,708 Amortization of stock-based compensation (1,093,370 ) (933,135 ) Other prepaid expense activity (80,443 ) 49,282 Sub-total 684,489 1,548,752 Less non-current portion 140,443 561,776 Prepaid expenses, current portion $ 544,046 $ 986,976 Property and equipment Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets. The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows: Vehicles and equipment 5 years Software 3 years Convertible Instruments The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. In August 2020, the FASB issued Accounting Standards Update 2020-06 (ASU 2020-06). ASU 2020-06 eliminates the beneficial conversion feature and cash conversion models in Accounting Standards Codification 470-20 that require separate accounting for embedded conversion features in convertible instruments. The new guidance also eliminates some of the conditions that must be met for equity classification under ASC 815-40-25. The standard is effective for smaller reporting companies for annual periods beginning after December 15, 2023. Early adoption is permitted. The Company chose to early adopt this standard. As a result, financial results contained herein are reported in accordance with this standard as applicable. The convertible debt issued by the Company referred to in Note 7, did not require separate accounting for the conversion feature as it was not considered to be a derivative. The Company issued warrants in connection with the debt financing and in accordance with ASC 470-20-25-2 the proceeds from the sale of the debt instruments have been allocated to the debt and warrants based on the relative fair value of the two components. The amount allocated to the warrants has been recorded as a debt discount to be amortized of the life of the note. Fair value of financial instruments The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities. ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, accounts payable and accrued expenses, related party liabilities, dividends payable, deferred revenue, convertible notes payable and note payable, approximate their fair values because of the short maturity of these instruments. Revenue recognition Our revenues are primarily generated from fees charged in connection with the implementation of our software platform (including the sale of SaaS products and services, maintenance associated with the sale of on premise software licenses). The Company has no outstanding contracts with any of its customers. Our revenue recognition policy follows the guidance from Accounting Standards Codification (“ASC”) 606, “Revenue Recognition,” and Accounting Standards Update No. 2014-09 - Revenue from Contracts with Customers (Topic 606) which provide guidance on the recognition, presentation, and disclosure of revenue in financial statements. We determine revenue recognition through the following steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract and (v) recognition of revenue when a performance obligation is satisfied. Revenue from fees charged in connection with the implementation of our software platform is recognized ratably over the term specified in the contract with the customers, which is primarily one year. The transaction price is the amount of consideration to which the Company expects to be entitled to receive in exchange for providing access to its platform. Maintenance and support services generally call for the Company to provide software updates and technical support to customers and is recognized ratably over the term of the contract as this is the period the services are delivered. The Company does not view the signing of the contract or the provision of initial setup services as discrete earnings events that are distinct. Our standard payment terms are generally no more than 60 days. SaaS and maintenance services are typically invoiced annually in advance. Amounts billed or collected in excess of revenue recognized are included as deferred revenue. Stock-based compensation The Company accounts for its stock based compensation under the recognition and measurement principles of the fair value recognition provisions of Statement of Financial Accounting Standards No. 123 (revised 2004) “Share-Based Payment” (ASC 718) using the modified prospective method for transactions in which the Company obtains employee services in share-based payment transactions and the Financial Accounting Standards Board Emerging Issues Task Force Issue No. 96-18 “Accounting For Equity Instruments That Are Issued To Other Than Employees For Acquiring, Or In Conjunction With Selling Goods Or Services” (“EITF No. 96-18”) for share-based payment transactions with parties other than employees provided in (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the third-party performance is complete or the date on which it is probable that performance will occur. Income taxes The Company accounts for income taxes under Statement of Financial Accounting Standards No. 109 “Accounting for Income Taxes” (“SFAS No. 109”) (ASC 740). Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date. Cash flows reporting The Company follows the provisions of ASC 230 for cash flows reporting and accordingly classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments. Reporting segments ASC 280 establishes standards for the way that public enterprises report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements regarding products and services, geographic areas and major customers. ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company’s financial statements as substantially all of the Company’s operations are conducted in one industry segment. Concentrations of Credit Risk The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited. Earnings (Loss) Per Share of Common Stock The Company has adopted ASC 260-10-20, “Earnings per Share,” (“EPS”) which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. Recent Accounting Pronouncements Other than the above there have been no recent accounting pronouncements or changes in accounting pronouncements during the year ended September 30, 2024, that are of significance or potential significance to the Company.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Sep. 30, 2024
PROPERTY AND EQUIPMENT
PROPERTY AND EQUIPMENT	NOTE 4 - PROPERTY AND EQUIPMENT The following table represents the Company’s property and equipment as of September 30, 2024, and 2023: September 30, 2024 2023 Property and equipment $ 245,606 $ 230,900 Accumulated depreciation (194,739 ) (153,342 ) Property and equipment, net $ 50,867 $ 77,558 Depreciation expense was $41,397 and $45,432 for the years ended September 30, 2024, and 2023, respectively.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Sep. 30, 2024
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 5 - RELATED PARTY TRANSACTIONS Related Party agreements and fees For the years ended September 30, 2024, and 2023, the Company recorded expenses to related parties in the following amounts: Years ended September 30, 2024 2023 Management fees, Chief Executive Officer (CEO) $ 180,000 $ 195,000 Chief Technology Officer (CTO) through March 31, 2023 - 105,000 Chief Administration Officer (CAO) through January 31, 2023 - 55,000 President and Chief Operating Officer (COO) 180,000 85,000 Stock-based compensation expense, officers 495,459 1,377,764 Office rent and expenses 15,602 25,737 Total $ 871,061 $ 1,843,501 As of October 1, 2022, the monthly fee for the CEO and CTO was $20,000. Effective January 1, 2023, the monthly fee for the CEO and CTO was reduced to $15,000. Effective April 1, 2023, the Company was no longer compensating the CTO and did not incur any additional CTO office rent and expenses. Effective February 1, 2023, the Company entered a Consulting Executive Officer Agreement with a three- year term to an entity to provide the services of a Chief Operating Officer (the “COO”) of the Company. On October 1, 2023, the BOD also appointed the COO as the President. Pursuant to the agreement, the Company agreed to a monthly fee of $10,000, and the issuance of 250,000 shares per month, to be certificated semi-annually. The monthly fee was increased to $15,000 per month effective September 1, 2023. For the years ended September 30, 2024, and 2023, the Company recorded expenses of $74,125 and $82,875, respectively, related to the 250,000 shares per month. On May 8, 2024, the Company issued 3,000,000 shares of common stock for the months of February 2023, through January 2024. On May 11, 2023, the Company issued 5,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. The Company valued the shares at $0.04 per share and included stock-based compensation expense-related party of $200,000 for the year ended September 30, 2023. On July 10, 2023, the Company issued 15,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. The Company valued the shares at $0.0406 per share and included stock-based compensation expense-related party of $609,000 for the year ended September 30, 2023. On September 7, 2023, the Company issued 5,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. The Company valued the shares at $0.041 per share and included stock-based compensation expense-related party of $205,000 for the year ended September 30, 2023. Additionally, the Company granted an option to purchase 10,000,000 shares of the Company’s common stock at $0.02 per share with an expiry date of July 1, 2025 (the "CYCA Option”). The CYCA option vests at the rate of 25% beginning on the first six-month anniversary of the agreement, as well as a warrant to purchase 250,000 shares of the Reticulate Micro common stock the Company owns (the “RM Warrant”). The RM Warrant has an exercise price of $1.00 per share and an expiry date of July 1, 2025. The Company valued the CYCA Option at $639,543 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $213,181, and $142,121 is included in stock-based compensation expense-related party for the years ended September 30, 2024, and 2023, respectively. The Company valued the RM Warrant at $624,458 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $208,153, and $138,768 is included in stock-based compensation expense-related party for the years ended September 30, 2024, and 2023, respectively. Beginning in April 2024, the Company agreed to rent office space for the COO at $2,575 per month, on a month to month basis, accordingly, $15,602 is included in related party expenses for the year ended September 30, 2024. On October 25, 2020, the Company entered a sublease with its CTO, whereby the Company agreed to an annual lease payment of $50,000. On October 26, 2021, the Company renewed the lease for an additional year for $3,500 per month, and on October 26, 2022, the lease was renewed on a month-to-month basis. The last month to month lease payment related to the agreement with the CTO was for March 2023, and accordingly, for the CTO rent, there is no expense for the year ended September 30, 2024. Included in related party expenses for the CTO office rent and other expenses for the year ended September 30, 2023, is $25,737. Related party liabilities As of September 30, 2024, and 2023, the Company owes $443,093 and $772,532, respectively, to related parties as follows: September 30, 2024 September 30, 2023 Management fees, Chief Executive Officer (CEO) $ 110,000 $ 110,000 Bonus, CEO 68,040 70,000 Stock to be issued President and COO 208,635 562,532 Accounts payable, President and COO 26,418 - Fees, bonus, and accounts payable, former CTO 30,000 30,000 Total $ 443,093 $ 772,532

NOTE PAYABLE

NOTE PAYABLE	12 Months Ended
	Sep. 30, 2024
NOTE PAYABLE
NOTES PAYABLE	NOTE 6 - NOTE PAYABLE On January 10, 2023, the Company entered into an 8%, $40,000 face value promissory note with a third-party lender with a maturity date the earlier of the Company raising $1,000,000 in debt or equity, or January 10, 2024. The lender may extend the maturity date for an additional one year at their option by providing 30 days written notice to the Company before the maturity date. Effective January 10, 2024, the lender amended and restated the note with a principal balance of $43,200, that matures on July 10, 2024, with an interest rate of 8% and pledged 45,000 shares of RM stock as collateral for the note. On August 12, 2024, the Company has agreed to transfer 45,000 shares of RM stock to RM (the lender) for satisfaction of the note and accrued and unpaid interest.

CONVERTIBLE NOTES PAYABLE

CONVERTIBLE NOTES PAYABLE	12 Months Ended
	Sep. 30, 2024
CONVERTIBLE NOTES PAYABLE
CONVERTIBLE NOTES PAYABLE	NOTE 7 - CONVERTIBLE NOTES PAYABLE During the quarter ended March 31, 2023, (the “March 2023 Notes”) the Company issued five (5) convertible promissory notes, in the aggregated principal amount of $160,000, to investors. The notes bear an interest rate of 18% per annum. Principal amount of $100,000 matured on July 1, 2024, and have been extended to July 1, 2025, while principal amount of $60,000 matured on various dates of February 2024 and have all been extended to May 31, 2025. Interest payments are due quarterly. The Holders shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of Reticulate Micro (the “RM Stock”) owned by the Company. The notes are convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025, or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note. In conjunction with one note of $50,000, the Company issued a warrant to purchase 2,000,000 shares of common stock at an exercise price of $0.025 with an expiration date of July 1, 2025, and a warrant to purchase 100,000 shares of RM Stock at $1.00 per share with an expiry date of July 1, 2025. The warrants issued to purchase the Company’s common stock, and the RM Stock resulted in a debt discount of $43,416, with the offset to additional paid in capital. For the years ended September 30, 2024, and 2023, amortization of the debt discounts of $23,549 and $19,867, respectively, was charged to interest expense. In conjunction with one note of $50,000, the Company issued a warrant to purchase 2,000,000 shares of common stock at an exercise price of $0.025 with an expiration date of July 1, 2025, and a warrant to purchase 100,000 shares of RM Stock at $1.00 per share with an expiry date of July 1, 2025. The warrants issued to purchase the Company’s common stock, and the RM Stock resulted in a debt discount of $43,585, with the offset to additional paid in capital. For the years ended September 30, 2024, and 2023, amortization of the debt discounts of $24,663 and $18,922, respectively, was charged to interest expense. As of September 30, 2024, and 2023, the outstanding principal balance of the March 2023 Notes was $160,000. During the quarter ended June 30, 2023, (the “June 2023 Notes”) the Company issued two (2) convertible promissory notes, in the aggregated principal amount of $550,000, to investors. The notes bear an interest rate of 18% per annum and matured during the quarter ended June 30, 2024. Interest payments are due quarterly. The Holders shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company. Of the notes, $500,000 are convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.025 or RM Stock at $1.00 per share, and $50,000 are convertible into shares of the Company’s common stock beginning on the Issuance Date at $0.02 or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the year ended September 30, 2024, the lenders of the June 2023 Notes agreed to settle the notes by the issuance of 550,000 shares of RM stock for the principal amount. As of September 30, 2024, and 2023, the outstanding principal balance of the June 2023 Notes was $0 and $550,000, respectively. During the quarter ended September 30, 2023, (the “September 2023 Notes”) the Company issued two (2) convertible promissory notes, in the aggregated principal amount of $505,000, to investors. The notes bear an interest rate of 18% per annum and mature during the quarter ended September 30, 2024. Interest payments are due quarterly. The Holders shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company’s common stock at $0.025 or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the year ended September 30, 2024, the lenders of the September 2023 Notes agreed to settle the notes by the issuance of 505,000 shares of RM stock for the principal amount. As of September 30, 2024, and 2023, the outstanding principal balance of the September 2023 Notes was $0 and $505,000, respectively. During the quarter ended December 31, 2023, (the “December 2023 Notes”) the Company issued a convertible promissory note of $40,000, to an investor. The note bears an interest rate of 18% per annum and matured during the quarter ended December 31, 2024, and has been extended to May 31, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $1.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $1.00 per share to equal the outstanding principal and interest due upon any defaults of the note. As of September 30, 2024, there is a balance due of $40,000 on the December 2023 Notes. During the quarter ended March 31, 2024, (the “March 2024 Notes”) the Company issued nine (9) convertible promissory notes in the aggregate of $517,500, to investors. The notes bear an interest rate of 18% per annum and mature during the quarter ended March 31, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $2.00 per share, excluding a note of $250,000 which has a conversion price of $1.00 of RM stock for principal and $2.50 of RM stock for interest. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $2.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the year ended September 30, 2024, the lenders of $167,500 of the March 2024 Notes agreed to settle the notes by the issuance of 83,750 shares of RM stock for the principal amount. As of September 30, 2024, there is a balance of $350,000 due on the March 2024 Notes. During the quarter ended June 30, 2024, (the “June 2024 Notes”) the Company issued thirty eight (38) convertible promissory notes in the aggregate of $1,910,950 to investors. The notes bear an interest rate of 18% per annum and mature during the quarter ended June 30, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $2.00 per share, excluding $85,000 of June 2024 Notes where the conversion price is $1.00 for the RM stock and $15,000 of June 2024 Notes where the conversion price is $0.025 for the Company’s common stock. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $2.00 per share to equal the outstanding principal and interest due upon any defaults of the note. During the year ended September 30, 2024, the lenders of $1,147,000 of the June 2024 Notes agreed to settle the notes by the issuance of 573,500 shares of RM stock for the principal amount. As of September 30, 2024, there is a balance of $763,950 due on the June 2024 Notes. During the quarter ended September 30, 2024, (the “September 2024 Notes”) the Company issued two (2) convertible promissory notes in the aggregate of $125,000 to investors. The notes bear an interest rate of 18% per annum and mature during the quarter ended September 30, 2025. Interest payments are due quarterly. The Holder shall have the right to convert all or any part of the outstanding and unpaid principal, interest, and any other amounts due into fully paid and non-assessable shares of common stock of the Company or to the Class A common stock of RM Stock owned by the Company beginning on the Issuance Date of the Company's common stock at $0.025 or RM Stock at $2.00 per share. The note proceeds will be used by the Company for general working capital purposes. The Company also agreed to pledge RM stock at $2.00 per share to equal the outstanding principal and interest due upon any defaults of the note. As of September 30, 2024, there is a balance of $125,000 due on the September 2024 Notes. The activity for the years ended September 30, 2024, and 2023, is summarized as follows: September 30, 2024 September 30, 2023 Beginning balance, face value $ 1,215,000 $ - Convertible notes issued 2,593,450 1,215,000 Convertible notes converted (2,369,500 ) - Convertible note discount - (48,212 ) Ending balance $ 1,438,950 $ 1,166,788 The Company has the following convertible notes payable outstanding as of September 30, 2024, and 2023: September 30, 2024 September 30, 2023 March 2023 Convertible notes payable, interest at 18%, $60,000 matures May 31, 2025, and $100,000 matures July 1, 2025, net of discount of $48,212 (September 30, 2023) $ 160,000 $ 111,788 June 2023 Convertible notes payable, interest at 18% - 550,000 September 2023 Convertible notes payable, interest at 18% - 505,000 December 2023 Convertible note payable, interest at 18%, matures May 31, 2025 40,000 - March 2024 Convertible notes payable, interest at 18%, matures during quarter ending March 31, 2025 350,000 - June 2024 Convertible notes payable, interest at 18%, matures during quarter ending June 30, 2025 763,950 - September 2024 Convertible notes payable, interest at 18%, matures during quarter ending September 30, 2025 125,000 - Convertible notes payable, net of discounts of $48,212 (September 30, 2023) $ 1,438,950 $ 1,166,788

CAPITAL STOCK

CAPITAL STOCK	12 Months Ended
	Sep. 30, 2024
CAPITAL STOCK
CAPITAL STOCK	NOTE 8 - CAPITAL STOCK Common Stock The Company has authorized 600,000,000 common shares, par value $0.001. Each common share entitles the holder to one vote, in person or proxy, on any matter on which action of the stockholders of the corporation is sought. As of September 30, 2024, and 2023, there were 469,877,826 and 426,831,170, respectively, common shares issued and outstanding. During the year ended September 30, 2024, the following shares of common stock were issued: · On September 6, 2024, the Company issued 2,559,558 shares of common stock for payment of $63,989 of accounts payable and accrued interest. The value of the shares issued was $73,715 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company recorded a $9,726 loss on debt extinguishment for this transaction. · On May 23, 2024, the Company issued 85,883 shares of common stock for payment of $1,718 of accounts payable and accrued interest. The value of the shares issued was $2,405 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company included $687 in loss on debt extinguishment for the year ended September 30, 2024. · On May 16, 2024, the Company issued 2,500,000 shares of common issued for services. The Company valued the shares at $75,000 based on the price of the common stock on the date the Company agreed to issue the shares and is included in stock-based consulting expense for the year ended September 30, 2024. · On May 16, 2024, the Company issued 5,000,000 shares of common issued for services. The Company valued the shares at $142,500 based on the price of the common stock on the date the Company agreed to issue the shares. The shares issued were earned pursuant to the execution of a one-year consulting agreement on May 1, 2024. Accordingly, for the year ended September 30, 2024, the Company recorded $142,500 of stock-based consulting expense. · On April 24, 2024, the Company issued 2,285,804 shares of common stock for payment of $56,584 of accounts payable and accrued interest. The value of the shares issued was $66,407 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company recorded a $9,823 loss on debt extinguishment for the year ended September 30, 2024, for this transaction. · On April 24, 2024, the Company issued 3,000,000 shares of common issued for payment of $108,250 of accrued liabilities, related. The Company valued the shares at $90,000 based on the price of the common stock on the date the Company issued the shares and included $18,250 gain on debt extinguishment for the year ended September 30, 2024, for this transaction. · On April 24, 2024, the Company issued 3,000,000 shares of common issued for services. The Company valued the shares at $62,400 based on the price of the common stock on the date the Company agreed to issue the shares. The shares were issued pursuant to a one-year consulting agreement beginning January 1, 2024. The company will amortize the value over the term of the contract. For the year ended September 30, 2024, the Company recorded $46,800 of stock-based consulting expense. · On April 24, 2024, the Company issued 3,000,000 shares of common issued for services. The Company valued the shares at $82,500 based on the price of the common stock on the date the Company agreed to issue the shares. For the year ended September 30, 2024, the Company recorded $82,500 of stock-based consulting expense. · On April 24, 2024, the Company issued 1,500,000 shares of common issued for services. The Company valued the shares at $33,750 based on the price of the common stock on the date the Company issued the shares. The shares were issued pursuant to a one-year consulting agreement beginning April 23, 2024. The company will amortize the value over the term of the contract. For the year ended September 30, 2024, the Company recorded $16,875 of stock-based consulting expense. · On April 24, 2024, the Company issued 2,500,000 shares of common issued for services. The Company valued the shares at $56,250 based on the price of the common stock on the date the Company issued the shares. The shares were issued pursuant to a one-year consulting agreement beginning April 23, 2024. The company will amortize the value over the term of the contract. For the year ended September 30, 2024, the Company recorded $28,125 of stock-based consulting expense. · On April 24, 2024, the Company issued 2,500,000 shares of common issued for services. The Company valued the shares at $68,750 based on the price of the common stock on the date the Company agreed to issue the shares. The shares were issued pursuant to a one-year consulting agreement beginning April 1, 2024. The company will amortize the value over the term of the contract. For the year ended September 30, 2024, the Company recorded $34,375 of stock-based consulting expense. · On January 18, 2024, the Company issued 5,000,000 shares of common issued for services. The Company valued the shares at $104,000 based on the price of the common stock on the date the Company agreed to issue the shares. The shares were issued pursuant to a one-year consulting agreement beginning January 1, 2024. The company will amortize the value over the term of the contract. For the year ended September 30, 2024, the Company recorded $78,000 of stock-based consulting expense. · On January 12, 2024, the Company issued 2,227,661 shares of common stock for payment of $55,124 of accounts payable and accrued interest. The value of the shares issued was $46,336 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company recorded an $8,788 gain on debt extinguishment for the year ended September 30, 2024. · On December 14, 2023, the Company issued 6,000,000 shares of common issued for services. The Company valued the shares at $169,200 based on the price of the common stock on the date the Company agreed to issue the shares and is included in stock-based consulting expense for the year ended September 30, 2024. · On November 30, 2023, the Company issued 1,887,750 shares of common stock for payment of $46,826 of accounts payable and accrued interest. The value of the shares issued was $50,781 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company included $3,955 in loss on debt extinguishment for the year ended September 30, 2024. During the year ended September 30, 2023, the following shares of common stock were issued: · 41,575,000 shares of common issued for services. The Company valued the shares at $2,175,819 based on the price of the common stock on the date the Company agreed to issue the shares. · 1,440,750 shares issued for payment of $47,269 of accounts payable and accrued interest. The value of the shares issued was $67,440 based upon the share price of the Company’s common stock on the date the Company agreed to issue the common stock. The Company included $20,171 in loss on debt extinguishment for the year ended September 30, 2023. · 54,750 shares of common stock were issued in settlement of stock payable. · 4,000,000 shares of common stock were issued pursuant to a stock subscription agreement. The Company sold the shares for $0.02 and sold 1) warrants to purchase 4,000,000 shares of common stock for $10,000. The warrant has an exercise price of $0.02 and expires July 1, 2024. The Company also sold for $10,000 warrants to purchase 200,000 shares of RM Stock for $1.00 with an expiry date of July 1, 2024. Preferred Stock The Company has 100,000,000 shares authorized as preferred stock, par value $0.001 (the “Preferred Stock”), which such Preferred Stock shall be issuable in such series, and with such designations, rights and preferences as the Board of Directors may determine from time to time. Series C Preferred Stock Under the terms of the Certificate of Designation of Series C Preferred Stock, 12,000,000 shares of the Company’s preferred shares are designated as Series C Preferred Stock. Each share of Series C Preferred Stock is convertible into one hundred shares Common Stock and each share of Series C Preferred Stock is entitled to one hundred votes. As of September 30, 2024, and 2023, there were 600,000 shares of Series C Preferred Stock issued and outstanding. Series D Preferred Stock On September 30, 2020, the Company filed an Amended and Restated Certificate of Designation with the State of Nevada of the Company’s Series D Preferred Stock. Under the terms of the Amendment to Certificate of Designation of Series D Preferred Stock, 10,000,000 shares of the Company’s preferred shares are designated as Series D Preferred Stock. Each share of Series D Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series D Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote on all shareholder matters equal to two times the sum of all the number of shares of other classes of Corporation capital stock eligible to vote on all matters submitted to a vote of the stockholders of the Corporation. As of September 30, 2024, and 2023, there were 50,000 shares of Series D Preferred Stock issued and outstanding. Series E Preferred Stock On June 2, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 13,650,000 (as amended on June 10, 2021) were designated as Series E Preferred Stock. Each share of Series E Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock. For so long as any shares of the Series E Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. As of September 30, 2024, and 2023, there were no shares of Series E Preferred stock issued and outstanding. Series F Preferred Stock On November 24, 2021, the Company filed a Certificate of Designation with the State of Nevada. Under the terms of the Certificate of Designation 59,270,000 were designated as Series F Preferred Stock. Each share of Series F Preferred Stock is convertible into one share of fully paid and non-assessable Common Stock at any time by the holder. For so long as any shares of the Series F Preferred Stock remain issued and outstanding, the Holders thereof, voting separately as a class, shall have the right to vote one share on all matters submitted to a vote of the stockholders of the Corporation. The Series F Preferred Stock automatically converts to common stock after the shares of common stock closing market price is at least $0.20 for twenty (20) consecutive trading days. As of September 30, 2024, and 2023, there were no shares of Series F Preferred Stock issued and outstanding. Stock Payable (Capital stock to be issued) As of September 30, 2022, the Company had $54,750 of capital stock to be issued. During the year ended September 30, 2023, the Company issued 54,750 shares of common stock, reducing the capital stock to be issued by $54,750. As of September 30, 2024, and 2023, there were no shares of capital stock to be issued. Stock Options The Company did not issue any stock options during the year ended September 30, 2024. On February 1, 2023, pursuant to a three-year consulting agreement, the Company granted an option to purchase 10,000,000 shares of common stock with an exercise price of $0.02 and an expiration date of July 1, 2025. The options vest over a two-year period at the rate of 25% every six months beginning on the six-month anniversary date of the agreement. The Company valued the option at $639,543 and will amortize the value over the three-year term of the agreement. For the years ended September 30, 2024, and 2023, the Company has included $213,181 and $142,121, respectively, in stock-based compensation expense, related party. On March 3, 2023, pursuant to a one-year consulting agreement, the Company granted an option to purchase 10,000,000 shares of common stock with an exercise price of $0.02 and an expiration date of July 1, 2025. The options vest over a two-year period at the rate of 25% every six months beginning on the six-month anniversary date of the agreement. The Company valued the option at $449,651 and will amortize the value over the one-year term of the agreement. For the years ended September 30, 2024, and 2023, the Company has included $187,354 and $262,297, respectively in stock-based compensation expense. The following table summarizes activities related to stock options of the Company for the years ended September 30, 2024, and 2023. Number of Options Weighted- Average Exercise Price per Share Weighted- Average Remaining Life (Years) Outstanding at October 1, 2022 - $ - - Issued 20,000,000 $ 0.02 2.37 Outstanding at September 30, 2023 20,000,000 $ 0.02 1.75 Exercisable at September 30, 2023 5,000,000 $ 0.02 - Outstanding at September 30, 2024 20,000,000 $ 0.02 0.75 Exercisable at September 30, 2024 15,000,000 $ 0.02 - As of September 30, 2024, 5,000,000 options to purchase shares of common stock remain unvested and $284,241 of stock compensation expense remains unrecognized and is being expensed over a weighted average period of 2.37 years from the date of the grant. Warrants On April 1, 2024, pursuant to a consulting agreement, the Company issued a warrant to purchase 50,000 shares of RM Stock that vested immediately and with an exercise price of $1.50 and an expiration date of April 1, 2025. The Company valued the warrant at $119,348 based on the Black Scholes option pricing model. The following assumptions were utilized in the Black-Scholes valuation of this immediately vested warrant during the year ended September 30, 2024, risk free interest rate of 5.03%, volatility of 145% and an exercise price of $1.50. Accordingly, $119,348 has been expensed for the year ended September 30, 2024, in stock-based compensation expense. On February 1, 2023, pursuant to a three-year consulting agreement, the Company granted a warrant to purchase 250,000 shares of RM common stock with an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the warrant at $624,458 and will amortize the value over the three-year term of the agreement. For the years ended September 30, 2024, and 2023, the Company has included $208,153 and $138,768, respectively, in stock-based compensation expense, related party. On February 8, 2023, an investor paid $5,000 to acquire a warrant to purchase 2,000,000 shares of common stock. The warrant has an exercise price of $0.02 per share and expires July 1, 2024. The Company also issued a warrant to purchase 100,000 shares of RM Stock, with an exercise price of $1.00 and an expiration date of July 1, 2025, as amended. On February 10, 2023, pursuant to a convertible note with a current shareholder of the Company, the Company issued a warrant to the investor to purchase 2,000,000 shares of common stock at an exercise price of $0.025 per share and an expiration date of July 1, 2025. The Company valued the warrant at $79,914, based on the Black Scholes option pricing model. The Company also issued a warrant to purchase 100,000 shares of RM Stock at an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the RM Stock warrant at $249,811, based on the Black Scholes option pricing model. The Company applied $43,416 to the note as a discount based on the allocations of the fair values of the warrants and the note. The Company will charge the note discount to interest expense over the term of the note. For the years ended September 30, 2024, and 2023, the Company recorded interest expense of $23,549 and $19,867, respectively. On March 1, 2023, an investor paid $5,000 to acquire a warrant to purchase 2,000,000 shares of common stock. The warrant has an exercise price of $0.02 per share and expires July 1, 2024. The Company also issued a warrant to purchase 100,000 shares of RM Stock, with an exercise price of $1.00 and an expiration date of July 1, 2025, as amended. On March 3, 2023, pursuant to a convertible note with a current shareholder of the Company, the Company issued a warrant to the investor to purchase 2,000,000 shares of common stock at an exercise price of $0.025 per share and an expiration date of July 1, 2025. The Company valued the warrant at $89,916, based on the Black Scholes option pricing model. The Company also issued a warrant to purchase 100,000 shares of RM Stock at an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the RM Stock warrant at $249,822, based on the Black Scholes option pricing model. The Company applied $43,585 to the note as a discount based on the allocations of the fair values of the warrants and the note. The Company will charge the note discount to interest expense over the term of the note. For the years ended September 30, 2024, and 2023 the Company recorded interest expenses of $24,662 and $18,923, respectively. On March 3, 2023, pursuant to a one-year consulting agreement with a Company shareholder, the Company issued to the shareholder a warrant to purchase 250,000 shares of RM Stock with an exercise price of $1.00 and an expiration date of July 1, 2025. The Company valued the warrant at $624,556 and will amortize the value over the one-year term of the agreement. For the years ended September 30, 2024, and 2023, the Company has included $260,232 and $364,324, respectively, in stock-based compensation expenses. The following table summarizes activities related to warrants of the Company for the years ended September 30, 2024, and 2023. Number of Warrants Weighted Average Exercise Price Per Share Weighted Average Remining Life (Years) Outstanding at October 1, 2022 -0- $ -0- -0- Issued 8,000,000 0.0225 1.86 Outstanding and exercisable at September 30, 2023 8,000,000 $ 0.0225 1.25 Expired or cancelled or forfeited (4,000,000 ) 0.0225 - Outstanding and exercisable at September 30, 2024 4,000,000 $ 0.0225 0.75 The following table summarizes activities related to warrants to purchase RM Stock from the Company for the years ended September 30, 2024, and 2023. Number of Warrants Weighted Average Exercise Price Per Share Weighted Average Remining Life (Years) Outstanding at October 1, 2022 -0- $ -0- -0- Issued 900,000 1.00 2.15 Outstanding and exercisable at September 30, 2023 900,000 $ 1.00 1.53 Issued 50,000 1.50 1.00 Outstanding and exercisable at September 30, 2024 950,000 $ 1.03 0.74

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Sep. 30, 2024
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 9 - COMMITMENTS AND CONTINGENCIES On November 24, 2020, a plaintiff (the “Plaintiff”) filed a complaint in the State District Court for Clark County, Nevada, naming Cytta as a Defendant. The Plaintiff contended that the Company had breached a written contract, or, in the alternative was liable to the Plaintiff for unjust enrichment. Cytta contended that no contract formation had ever occurred and that it had not been unjustly enriched by the Plaintiff. On or about January 15, 2021, the Defendant filed an Answer and Counterclaim in the litigation and contended that in fact the Plaintiff owed money to Cytta. A bench trial was held in June of 2022. In May of 2023, the Court which had presided over the bench trial ruled against the Plaintiff and in favor of Cytta, rejecting all the Plaintiff’s claims against Cytta. The Court also awarded damages to Cytta, and against the Plaintiff, on one of Cytta’s counterclaims, and subsequently also ruled that Cytta is entitled to recover certain of its costs and fees from the Plaintiff. The Plaintiff’s lawyer subsequently withdrew from representing the Plaintiff. The Plaintiff thereafter filed a pro se appeal without a lawyer. That Pro Se appeal has now been dismissed. On July 19, 2022, the Company entered an Investor Awareness Advisory Services Agreement with a third party. Pursuant to the agreement in exchange for $10,000 per month over the three-month term (the “Term”) of the agreement, the third party will provide investor awareness advisory services (the “Services”). In addition, at the end of the Term, based upon the Company’s satisfaction with the Services, the Company will issue 500,000 shares of common stock to the provider’s designee. The shares were issued in December 2022. The Company recorded stock-based compensation expense of $50,000 for the year ended September 30, 2023. On August 4, 2022 (the “Effective Date”), the Company entered a Consulting Agreement with a third party. Pursuant to the agreement in exchange for 1,300,000 shares of restricted common stock over the one-year term of the agreement, the third party will provide financial consulting services to the Company. The shares are to be issued on a pro-rata basis, whereby the initial 325,000 shares were issued on August 8, 2022, and a total of 975,000 shares were issued during the year ended September 30, 2023. The Company recorded stock-based compensation expense of $150,150 for the year ended September 30, 2023. On November 16, 2022 (the “Effective Date”), the Company entered a Consulting Agreement with a third party. Pursuant to the agreement in exchange for 1,000,000 shares of restricted common stock over the one-year term of the agreement the third party will provide financial consulting services to the Company. On December 5, 2022, the Company issued 500,000 shares and the remaining 500,000 shares were issued in September 2023. For the year ended September 30, 2023, the Company recorded stock-based compensation expense of $86,000 for the issuance of 1,000,000 shares. On December 2, 2022 (the “Effective Date”), the Company entered a Consulting Agreement with a third party. Pursuant to the agreement in exchange for 1,000,000 shares of restricted common stock. The shares were issued December 5, 2022. For the year ended September 30, 2023, the Company recorded stock-based compensation expense of $100,000 for the issuance of 1,000,000 shares. On December 5, 2022, the Company issued 1,200,000 shares of common stock for services rendered pursuant to a consulting agreement. For the year ended September 30, 2023, the Company recorded stock-based compensation of $120,000 for the issuance. The Company also agreed to pay a monthly fee of $5,000 per month. Additionally for the year ended September 30, 2023, the Company recorded stock compensation expense of $55,393, for the issuance of 500,000 shares of restricted common stock. The shares were issued February 14, 2023. Effective February 1, 2023, the Company entered a Consulting Executive Officer Agreement with a three- year term to an entity to provide the services of a Chief Operating Officer (the “COO”) of the Company. On October 1, 2023, the BOD also appointed the COO as the President. Pursuant to the agreement, the Company agreed to a monthly fee of $10,000, and the issuance of 250,000 shares per month, to be certificated semi-annually. The monthly fee was increased to $15,000 per month effective September 1, 2023. For the years ended September 30, 2024, and 2023, the Company recorded expenses of $74,125 and $82,875, respectively, related to the 250,000 shares per month. On May 8, 2024, the Company issued 3,000,000 shares of common stock for the months of February 2023, through January 2024. On May 11, 2023, the Company issued 5,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. The Company valued the shares at $0.04 per share and included stock-based compensation expense-related party of $200,000 for the year ended September 30, 2023. On July 10, 2023, the Company issued 15,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. The Company valued the shares at $0.0406 per share and included stock-based compensation expense-related party of $609,000 for the year ended September 30, 2023. On September 7, 2023, the Company issued 5,000,000 shares to the Company’s COO as a bonus pursuant to their Consulting Agreement. The Company valued the shares at $0.041 per share and included stock-based compensation expense-related party of $205,000 for the year ended September 30, 2023. Additionally, the Company granted an option to purchase 10,000,000 shares of the Company’s common stock at $0.02 per share with an expiry date of July 1, 2025 (the "CYCA Option”). The CYCA option vests at the rate of 25% beginning on the first six-month anniversary of the agreement, as well as a warrant to purchase 250,000 shares of the Reticulate Micro common stock the Company owns (the “RM Warrant”). The RM Warrant has an exercise price of $1.00 per share and an expiry date of July 1, 2025. The Company valued the CYCA Option at $639,543 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $213,181, and $142,121 is included in stock-based compensation expense-related party for the years ended September 30, 2024, and 2023, respectively. The Company valued the RM Warrant at $624,458 based on the Black-Scholes option pricing method and will be amortized through the term of the agreement, and accordingly, $208,153, and $138,768 is included in stock-based compensation expense-related party for the years ended September 30, 2024, and 2023, respectively. On March 3, 2023, the Company entered a Consulting Agreement with an investor. Pursuant to the agreement, the Company issued 2,000,000 shares of common stock for one year of services. The Company valued the shares at $80,000 based on the price of the common stock on the date the Company agreed to issue the common stock. The Company also issued the consultant 1) an option to purchase 10,000,000 shares of the Company’s common stock at an exercise price of $0.02 per share with an expiry date of July 1, 2025. The options vest over the two-year period in 25% increments beginning on the six- month anniversary of the agreement and 2) a warrant to purchase 250,000 shares of RM Stock at an exercise price of $1.00 per share with an expiry date of July 1, 2025. The option to purchase the Company’s common stock was valued at $449,651 based on the Black Scholes option pricing model and will be amortized over the one-year term of the agreement. For the years ended September 30, 2024, and 2023, $187,354 and $262,297, respectively, is included in stock-based compensation expense. The warrant to purchase the RM Stock was valued at $624,556 based on the Black Scholes option pricing model and will be amortized over the one-year term of the agreement. For the years ended September 30, 2024, and 2023, $260,232 and $364,324, respectively, is included in stock-based compensation expense. On May 11, 2023, the Company issued an additional 5,000,000 shares to the Consultant. The Company valued the shares at $0.04 per share and included stock-based compensation expense of $200,000 for the year ended September 30, 2023. On December 6, 2023, the Company agreed to issue an additional 6,000,000 shares of common stock. The Company valued the 6,000,000 shares at $0.0282 per share and included stock-based compensation expense of $169,200 for the year ended September 30, 2024. On May 16, 2024, the Company agreed to issue an additional 2,500,000 shares of common stock. The Company valued the 2,500,000 shares at $0.03 per share and included stock-based compensation expense of $75,000 for the year ended September 30, 2024. On April 1, 2023, the Company entered a Consulting Agreement with a third party for marketing services in exchange for 250,000 shares of restricted common stock. The shares vest in 12 equal amounts of 20,833. For the years ended September 30, 2024, and 2023, the Company has recorded stock-based compensation of $6,012 and $6,012, respectively, with the offset to accounts payable and accrued expenses. On October 1, 2023, the Company entered into a one-year Agreement for Board of Advisor Services with a third party to provide general technical, AI, sales, and marketing services in exchange for 3,000,000 shares of common stock. The Company valued the shares at $80,700 ($0.0269 per share). The shares are to be issued at the end of the term, and the Company is amortizing the expense over the term of the contract. For the year ended September 30, 2024, the Company included $80,700 in General and Administrative expenses and in accounts payable and accrued expenses. Effective May 1, 2024, the Company amended the October 1, 2023, agreement and agreed to issue 7,000,000 shares, of which 5,000,000 were immediately earned and were issued May 16, 2024, and to issue an additional 2,000,000 shares at the end of the term. The Company valued the 5,000,000 shares at $142,500 ($0.0285 per share) and the Company is amortizing the expense related to the 2,000,000 shares (valued at $57,000) over the term of the contract. For the year ended September 30, 2024, the Company included $166,250 in General and Administrative expenses and $23,750 in accounts payable and accrued expenses. On January 1, 2024, the Company entered into a one-year Consulting Agreement with a third party to provide market awareness services and the identification, evaluation, structuring, negotiating, and closing of joint ventures, strategic alliances, and business acquisitions, in exchange for 3,000,000 shares of common stock. The Company valued the shares at $62,400 and is amortizing the expense over the term of the contract. For the year ended September 30, 2024, the Company included $46,800 in General and Administrative expenses. The 30,000,000 shares of common stock were issued May 8, 2024. On January 2, 2024, the Company entered into a one-year Consulting Agreement with a third party to provide market awareness services and the identification, evaluation, structuring, negotiating, and closing of joint ventures, strategic alliances, and business acquisitions, in exchange for a monthly fee of $10,000 per month and 5,000,000 shares of common stock. The shares were issued on January 18, 2024. The Company valued the shares at $104,000 and is amortizing the expense over the term of the contract. For the year ended September 30, 2024, the Company included $78,003 in General and Administrative expenses. On March 19, 2024, the Company entered into a one-year Consulting Agreement with a third party to provide general business, military, governmental, technical, AI, and sales and marketing services, in exchange for 3,000,000 shares of common stock. The Company valued the shares at $78,000 and is amortizing the expense over the term of the contract. For the year ended September 30, 2024, the Company included $6,500 in General and Administrative expenses and in accounts payable and accrued expenses. The consultant never provided any services, and accordingly, the Company did not issue the shares. On April 1, 2024, the Company entered an Agreement for Board of Advisor Services with a third party to provide general business, military, governmental, technical, AI, and sales and marketing services, in exchange for 2,500,000 shares of common stock upon execution of the agreement (the “Initial Issuance”) and a further 2,500,000 shares of common stock one year after the execution (the “Final Issuance”). The Initial Issuance of 2,500,000 shares of common stock were issued on May 8, 2024. The Company valued the shares at $137,500 and is amortizing the expense over the term of the contract. For the year ended September 30, 2024, the Company included $68,749 in General and Administrative expenses. In connection with the agreement, the Company also agreed to issue a warrant to purchase 50,000 Class A common stock shares of RM Stock owned by the Company, at $1.50 per share and vested immediately. The warrant to purchase the RM Stock was valued at $119,348 based on the Black Scholes option pricing model and has been expensed in the year ended September 30, 2024, in general and administrative expenses. On April 23, 2024, the Company entered an Agreement for Board of Advisor Services with a third party to provide assistance to the Company in building its in house development team and manage software projects, in exchange for 3,000,000 shares of common stock. The Company issued 1,500,000 shares of common stock on May 8, 2024, with the balance due on the one-year anniversary of the agreement. The Company valued the shares at $67,500 and is amortizing the expense over the term of the contract. For the year ended September 30, 2024, the Company included $33,750 in General and Administrative expenses. On April 23, 2024, the Company entered an Agreement for Board of Advisor Services with a third party to provide general business, military, governmental, technical, AI, and sales and marketing services, in exchange for 5,000,000 shares of common stock. The Company issued 2,500,000 shares of common stock on May 8, 2024, with the balance due on the one-year anniversary of the agreement. The Company valued the shares at $112,500 and is amortizing the expense over the term of the contract. For the year ended September 30, 2024, the Company included $56,250 in General and Administrative expenses.

LICENSE AGREEMENT

LICENSE AGREEMENT	12 Months Ended
	Sep. 30, 2024
LICENSE AGREEMENT
LICENSE AGREEMENT	NOTE 10 - LICENSE AGREEMENT On August 9, 2022, the Company signed an Intellectual Property License Agreement (the “IPLA”) with Reticulate Micro, Inc. (“RM”). Pursuant to the ten-year term (the “Term”) of IPLA, RM agreed to issue to the Company 5,100,000 shares of RM’s Class A Common Stock and a royalty of 5% of net sales during the Term in exchange for the licensing of the Company’s technology related to its’ SUPR ISR (the Superior Utilization of Processing Resources- Intelligence, Surveillance and Reconnaissance). RM, a Nevada corporation, was formed on June 22, 2022. Mr. Collins, the Company’s’ former CTO was a co-founder, and a former Director and President and Treasurer of RM. Mr. Chermak, the Company’s former COO is a co-founder, Director and Vice-president and Secretary of RM. Mr. Ansari is a co-founder and former Director of RM. RM had initially issued 1,600,000, 1,000,000 and 1,000,000 shares of Class B Common Stock to Mr. Collins. Mr. Chermak and Mr. Ansari, respectively. On May 15, 2023, Mr. Collins cancelled his 1,600,000 shares of Class B common stock in exchange for 200,000 shares of Class A common stock. As of September 30, 2024, and 2023, RM has 2,000,000 and 2,000,000 Class B Common Stock shares outstanding, respectively. Each share of the Class B Common Stock has voting rights whereby each share of Class B Common Stock equals 100 voting shares. As of September 30, 2024, and 2023, RM had 10,459,199 and 8,257,714 Class A common stock shares issued and outstanding, respectively. During the year ended September 30, 2024, the Company has agreed to issue 1,798,767 shares of RM stock (1,780,531 has been issued and an additional 18,236 shares to be issued) in satisfaction of $2,369,500 of principal of convertible notes and $84,888 of accrued interest. The Company also issued 45,000 shares of RM stock in satisfaction of note payable (principal and interest). In connection with such issuance of RM stock in satisfaction of note and convertible notes principal and accrued and unpaid interest, the Company recognized an amount of $2,499,388 upon conversion, which was included in the additional paid-in capital for the year ended September 30, 2024. Accordingly, as of September 30, 2024, and 2023, the Company’s 3,301,233 and 5,100,000 respectively, shares of Class A Common Stock represent approximately 1.57% and 2.49%, respectively of the voting stock of RM. Each share of the Class B Common stock is also convertible into one share of Class A Common Stock. The Company accounts for its interest in RM under the cost method of accounting. Due to RM just being formed at the time of the license agreement no value has been assigned to the investment.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Sep. 30, 2024
INCOME TAXES
INCOME TAXES	NOTE 11 - INCOME TAXES The Company provides for income taxes under ASC 740, Accounting for Income Taxes. ASC 740 requires the use of an asset and liability approach in accounting for income taxes. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. ASC 740 requires the reduction of deferred tax assets by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. In assessing the need for a valuation allowance, management must determine that there will be sufficient taxable income to allow for the realization of deferred tax assets. Based upon the historical and anticipated future income, management has determined that the deferred tax assets do not meet the more-likely-than-not threshold for realizability. Accordingly, there is a full valuation allowance provided against the Company’s deferred tax assets as of September 30, 2024, and 2023. A reconciliation of the provision for income taxes determined at the U.S. statutory rate to the Company’s effective income tax rate is as follows: Year Ended September 30, 2024 2023 Pre-tax loss $ (4,264,412 ) $ (4,728,473 ) U.S. federal corporate income tax rate 21 % 21 % Expected U.S. income tax credit (895,527 ) (992,979 ) Permanent differences 423,402 658,631 Change of valuation allowance 472,125 334,348 Effective tax expense $ — $ — The Company had deferred tax assets as follows: September 30, 2024 September 30, 2023 Net operating losses carried forward $ 2,445,350 $ 1,973,226 Less: Valuation allowance (2,445,350 ) (1,973,226 ) Net deferred tax assets $ — $ — As of September 30, 2024, and 2023, the Company has approximately $11,645,000 and $9,396,000, respectively, net operating loss carryforwards available to reduce future taxable income. As of September 30, 2024, and 2023, the Company has no material unrecognized tax benefits which would favorably affect the effective income tax rate in future periods and does not believe that there will be any significant increases or decreases of unrecognized tax benefits within the next twelve months. No interest or penalties relating to income tax matters have been imposed on the Company during the years ended September 30, 2024, and 2023, and no provision for interest and penalties is deemed necessary as of September 30, 2024, and 2023.

DEFERRED REVENUE

DEFERRED REVENUE	12 Months Ended
	Sep. 30, 2024
DEFERRED REVENUE
DEFERRED REVENUE	NOTE 12 - DEFERRED REVENUE During the years ended September 30, 2024, and 2023, the Company delivered $4,995 and $32,470 in the aggregate of software products to customers under one year subscription periods. The Company records the agreed amounts over the one-year term of the subscription agreements as deferred revenue, classified as a liability on the balance sheet, and amortizes the deferred revenue over the subscription period. For the years ended September 30, 2024, and 2023, the Company recognized $4,492 and $30,059 of revenue from these agreements, respectively. As of September 30, 2024, and 2023, the balance of deferred revenues of $2,914 and $2,411 is included in the balance sheet, respectively.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Sep. 30, 2024
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 13 - SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date the financial statements were issued. The Company has determined that there are no such events that warrant disclosure or recognition in the financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Sep. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	The accompanying financial statements are prepared in accordance with Generally Accepted Accounting Principles in the United States of America (“US GAAP”).
Use of Estimates	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reported period. Actual results could differ from those estimates.
Cash and Cash Equivalents	The Company considers all highly liquid investments with an original term of three months or less to be cash equivalents. These investments are carried at cost, which approximates fair value. Cash and cash equivalent balances may, at certain times, exceed federally insured limits. The Company has no cash equivalents at September 30, 2024, and 2023.
Prepaid expenses	The Company considers expenses or services paid for prior to the period the expense is completed to be recorded as a prepaid expense. Included in this account is the value of common stock, options and warrants issued to consultants. Such issuances are pursuant to consulting agreements that can have a one-to-two-year term. The Company amortized the value of the stock issued over the term of the agreement. The activity for the years ended September 30, 2024, and 2023 is summarized as: September 30, 2024 2023 Balance beginning of period $ 1,548,752 $ 32,897 Value of common stock issued 309,550 2,399,708 Amortization of stock-based compensation (1,093,370 ) (933,135 ) Other prepaid expense activity (80,443 ) 49,282 Sub-total 684,489 1,548,752 Less non-current portion 140,443 561,776 Prepaid expenses, current portion $ 544,046 $ 986,976
Property and equipment	Property and equipment are stated at cost, and depreciation is provided by use of a straight-line method over the estimated useful lives of the assets. The Company reviews property and equipment for potential impairment whenever events or changes in circumstances indicate that the carrying amounts of assets may not be recoverable. The estimated useful lives of property and equipment is as follows: Vehicles and equipment 5 years Software 3 years
Convertible Instruments	The Company evaluates and accounts for conversion options embedded in convertible instruments in accordance with ASC 815, Derivatives and Hedging Activities. GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free-standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not remeasured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. In August 2020, the FASB issued Accounting Standards Update 2020-06 (ASU 2020-06). ASU 2020-06 eliminates the beneficial conversion feature and cash conversion models in Accounting Standards Codification 470-20 that require separate accounting for embedded conversion features in convertible instruments. The new guidance also eliminates some of the conditions that must be met for equity classification under ASC 815-40-25. The standard is effective for smaller reporting companies for annual periods beginning after December 15, 2023. Early adoption is permitted. The Company chose to early adopt this standard. As a result, financial results contained herein are reported in accordance with this standard as applicable. The convertible debt issued by the Company referred to in Note 7, did not require separate accounting for the conversion feature as it was not considered to be a derivative. The Company issued warrants in connection with the debt financing and in accordance with ASC 470-20-25-2 the proceeds from the sale of the debt instruments have been allocated to the debt and warrants based on the relative fair value of the two components. The amount allocated to the warrants has been recorded as a debt discount to be amortized of the life of the note.
Fair value of financial instruments	The Company measures assets and liabilities at fair value based on an expected exit price as defined by the authoritative guidance on fair value measurements, which represents the amount that would be received on the sale of an asset or paid to transfer a liability, as the case may be, in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level. The following are the hierarchical levels of inputs to measure fair value: ● Level 1 - Observable inputs that reflect quoted market prices in active markets for identical assets or liabilities. ● Level 2 - Inputs reflect quoted prices for identical assets or liabilities in markets that are not active; quoted prices for similar assets or liabilities in active markets; inputs other than quoted prices that are observable for the assets or liabilities; or inputs that are derived principally from or corroborated by observable market data by correlation or other means. ● Level 3 - Unobservable inputs reflecting the Company’s assumptions incorporated in valuation techniques used to determine fair value. These assumptions are required to be consistent with market participant assumptions that are reasonably available. The carrying amounts of the Company’s financial assets and liabilities, such as cash, prepaid expenses, accounts payable and accrued expenses, related party liabilities, dividends payable, deferred revenue, convertible notes payable and note payable, approximate their fair values because of the short maturity of these instruments.
Revenue recognition	Our revenues are primarily generated from fees charged in connection with the implementation of our software platform (including the sale of SaaS products and services, maintenance associated with the sale of on premise software licenses). The Company has no outstanding contracts with any of its customers. Our revenue recognition policy follows the guidance from Accounting Standards Codification (“ASC”) 606, “Revenue Recognition,” and Accounting Standards Update No. 2014-09 - Revenue from Contracts with Customers (Topic 606) which provide guidance on the recognition, presentation, and disclosure of revenue in financial statements. We determine revenue recognition through the following steps: (i) identification of the contract, or contracts, with a customer; (ii) identification of the performance obligations in the contract; (iii) determination of the transaction price; (iv) allocation of the transaction price to the performance obligations in the contract and (v) recognition of revenue when a performance obligation is satisfied. Revenue from fees charged in connection with the implementation of our software platform is recognized ratably over the term specified in the contract with the customers, which is primarily one year. The transaction price is the amount of consideration to which the Company expects to be entitled to receive in exchange for providing access to its platform. Maintenance and support services generally call for the Company to provide software updates and technical support to customers and is recognized ratably over the term of the contract as this is the period the services are delivered. The Company does not view the signing of the contract or the provision of initial setup services as discrete earnings events that are distinct. Our standard payment terms are generally no more than 60 days. SaaS and maintenance services are typically invoiced annually in advance. Amounts billed or collected in excess of revenue recognized are included as deferred revenue.
Stock-based compensation	The Company accounts for its stock based compensation under the recognition and measurement principles of the fair value recognition provisions of Statement of Financial Accounting Standards No. 123 (revised 2004) “Share-Based Payment” (ASC 718) using the modified prospective method for transactions in which the Company obtains employee services in share-based payment transactions and the Financial Accounting Standards Board Emerging Issues Task Force Issue No. 96-18 “Accounting For Equity Instruments That Are Issued To Other Than Employees For Acquiring, Or In Conjunction With Selling Goods Or Services” (“EITF No. 96-18”) for share-based payment transactions with parties other than employees provided in (ASC 718). All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. The measurement date used to determine the fair value of the equity instrument issued is the earlier of the date on which the third-party performance is complete or the date on which it is probable that performance will occur.
Income taxes	The Company accounts for income taxes under Statement of Financial Accounting Standards No. 109 “Accounting for Income Taxes” (“SFAS No. 109”) (ASC 740). Deferred income tax assets and liabilities are determined based upon differences between the financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance to the extent management concludes it is more likely than not that the assets will not be realized. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the statements of operations in the period that includes the enactment date.
Cash flows reporting	The Company follows the provisions of ASC 230 for cash flows reporting and accordingly classifies cash receipts and payments according to whether they stem from operating, investing, or financing activities and provides definitions of each category, and uses the indirect or reconciliation method (“Indirect method”) as defined by ASC 230 to report net cash flow from operating activities by adjusting net income to reconcile it to net cash flow from operating activities by removing the effects of (a) all deferrals of past operating cash receipts and payments and all accruals of expected future operating cash receipts and payments and (b) all items that are included in net income that do not affect operating cash receipts and payments.
Reporting segments	ASC 280 establishes standards for the way that public enterprises report information about operating segments in annual financial statements and requires reporting of selected information about operating segments in interim financial statements regarding products and services, geographic areas and major customers. ASC 280 defines operating segments as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performances. Currently, ASC 280 has no effect on the Company’s financial statements as substantially all of the Company’s operations are conducted in one industry segment.
Concentrations of Credit Risk	The Company’s financial instruments that are exposed to concentrations of credit risk primarily consist of its cash and cash equivalents and related party payables it will likely incur in the near future. The Company places its cash and cash equivalents with financial institutions of high credit worthiness. At times, its cash and cash equivalents with a particular financial institution may exceed any applicable government insurance limits. The Company’s management plans to assess the financial strength and credit worthiness of any parties to which it extends funds, and as such, it believes that any associated credit risk exposures are limited.
Earnings (Loss) Per Share of Common Stock	The Company has adopted ASC 260-10-20, “Earnings per Share,” (“EPS”) which requires presentation of basic and diluted EPS on the face of the income statement for all entities with complex capital structures and requires a reconciliation of the numerator and denominator of the basic EPS computation to the numerator and denominator of the diluted EPS computation. In the accompanying financial statements, basic earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period.
Recent Accounting Pronouncements	Other than the above there have been no recent accounting pronouncements or changes in accounting pronouncements during the year ended September 30, 2024, that are of significance or potential significance to the Company.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Sep. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Schedule of amortization of the value of the stock issued	September 30, 2024 2023 Balance beginning of period $ 1,548,752 $ 32,897 Value of common stock issued 309,550 2,399,708 Amortization of stock-based compensation (1,093,370 ) (933,135 ) Other prepaid expense activity (80,443 ) 49,282 Sub-total 684,489 1,548,752 Less non-current portion 140,443 561,776 Prepaid expenses, current portion $ 544,046 $ 986,976

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Sep. 30, 2024
PROPERTY AND EQUIPMENT
Schedule of property and equipment	September 30, 2024 2023 Property and equipment $ 245,606 $ 230,900 Accumulated depreciation (194,739 ) (153,342 ) Property and equipment, net $ 50,867 $ 77,558

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	12 Months Ended
	Sep. 30, 2024
RELATED PARTY TRANSACTIONS
Schedule of recorded expenses to related parties	Years ended September 30, 2024 2023 Management fees, Chief Executive Officer (CEO) $ 180,000 $ 195,000 Chief Technology Officer (CTO) through March 31, 2023 - 105,000 Chief Administration Officer (CAO) through January 31, 2023 - 55,000 President and Chief Operating Officer (COO) 180,000 85,000 Stock-based compensation expense, officers 495,459 1,377,764 Office rent and expenses 15,602 25,737 Total $ 871,061 $ 1,843,501
Schedule of Accounts payable related parties	September 30, 2024 September 30, 2023 Management fees, Chief Executive Officer (CEO) $ 110,000 $ 110,000 Bonus, CEO 68,040 70,000 Stock to be issued President and COO 208,635 562,532 Accounts payable, President and COO 26,418 - Fees, bonus, and accounts payable, former CTO 30,000 30,000 Total $ 443,093 $ 772,532

CONVERTIBLE NOTES PAYABLE (Tabl

CONVERTIBLE NOTES PAYABLE (Tables)	12 Months Ended
	Sep. 30, 2024
CONVERTIBLE NOTES PAYABLE
Schedule of notes payable	September 30, 2024 September 30, 2023 Beginning balance, face value $ 1,215,000 $ - Convertible notes issued 2,593,450 1,215,000 Convertible notes converted (2,369,500 ) - Convertible note discount - (48,212 ) Ending balance $ 1,438,950 $ 1,166,788 September 30, 2024 September 30, 2023 March 2023 Convertible notes payable, interest at 18%, $60,000 matures May 31, 2025, and $100,000 matures July 1, 2025, net of discount of $48,212 (September 30, 2023) $ 160,000 $ 111,788 June 2023 Convertible notes payable, interest at 18% - 550,000 September 2023 Convertible notes payable, interest at 18% - 505,000 December 2023 Convertible note payable, interest at 18%, matures May 31, 2025 40,000 - March 2024 Convertible notes payable, interest at 18%, matures during quarter ending March 31, 2025 350,000 - June 2024 Convertible notes payable, interest at 18%, matures during quarter ending June 30, 2025 763,950 - September 2024 Convertible notes payable, interest at 18%, matures during quarter ending September 30, 2025 125,000 - Convertible notes payable, net of discounts of $48,212 (September 30, 2023) $ 1,438,950 $ 1,166,788

CAPITAL STOCK (Tables)

CAPITAL STOCK (Tables)	12 Months Ended
	Sep. 30, 2024
CAPITAL STOCK
Schedule of activities related to stock options	Number of Options Weighted- Average Exercise Price per Share Weighted- Average Remaining Life (Years) Outstanding at October 1, 2022 - $ - - Issued 20,000,000 $ 0.02 2.37 Outstanding at September 30, 2023 20,000,000 $ 0.02 1.75 Exercisable at September 30, 2023 5,000,000 $ 0.02 - Outstanding at September 30, 2024 20,000,000 $ 0.02 0.75 Exercisable at September 30, 2024 15,000,000 $ 0.02 -
Schedule of activities related to warrants	Number of Warrants Weighted Average Exercise Price Per Share Weighted Average Remining Life (Years) Outstanding at October 1, 2022 -0- $ -0- -0- Issued 8,000,000 0.0225 1.86 Outstanding and exercisable at September 30, 2023 8,000,000 $ 0.0225 1.25 Expired or cancelled or forfeited (4,000,000 ) 0.0225 - Outstanding and exercisable at September 30, 2024 4,000,000 $ 0.0225 0.75 Number of Warrants Weighted Average Exercise Price Per Share Weighted Average Remining Life (Years) Outstanding at October 1, 2022 -0- $ -0- -0- Issued 900,000 1.00 2.15 Outstanding and exercisable at September 30, 2023 900,000 $ 1.00 1.53 Issued 50,000 1.50 1.00 Outstanding and exercisable at September 30, 2024 950,000 $ 1.03 0.74

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Sep. 30, 2024
INCOME TAXES
Schedule of provision for income taces	Year Ended September 30, 2024 2023 Pre-tax loss $ (4,264,412 ) $ (4,728,473 ) U.S. federal corporate income tax rate 21 % 21 % Expected U.S. income tax credit (895,527 ) (992,979 ) Permanent differences 423,402 658,631 Change of valuation allowance 472,125 334,348 Effective tax expense $ — $ —
Schedule of deferred tax assets	September 30, 2024 September 30, 2023 Net operating losses carried forward $ 2,445,350 $ 1,973,226 Less: Valuation allowance (2,445,350 ) (1,973,226 ) Net deferred tax assets $ — $ —

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
GOING CONCERN
Accumulated deficit	$ (36,867,892)	$ (32,603,480)
Convertible notes issued	2,593,450
Proceeds from Convertible Notes	$ 2,593,450

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	Sep. 30, 2024	Sep. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Prepaid expenses beginning balance	$ 1,548,752	$ 32,897
Value of common stock issued	309,550	2,399,708
Amortization of stock-based compensation	(1,093,370)	(933,135)
Other prepaid expense activity	(80,443)	49,282
Prepaid expenses ending balance	684,489	1,548,752
Prepaid expenses non-current portion	140,443	561,776
Prepaid expenses current portion	$ 544,046	$ 986,976

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	12 Months Ended
	Sep. 30, 2024
Vehicles And Equipment [Member]
Property Plant And Equipment Usefu Life	5 years
Software [Member]
Property Plant And Equipment Usefu Life	3 years

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Sep. 30, 2024	Sep. 30, 2023
PROPERTY AND EQUIPMENT
Property and equipments	$ 245,606	$ 230,900
Accumulated depreciation	(194,739)	(153,342)
Property and equipment, Net	$ 50,867	$ 77,558

PROPERTY AND EQUIPMENT (Detai_2

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
PROPERTY AND EQUIPMENT
Depreciation expenses	$ 41,397	$ 45,432

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
General and administrative - related party	$ 871,061	$ 1,843,501
Management fees, Chief Executive Officer (CEO) [Member]
General and administrative - related party	180,000	195,000
Chief Technology Officer [Member]
General and administrative - related party	0	105,000
Chief Administration Officer [Member]
General and administrative - related party	0	55,000
Chief Operating Officer [Member]
General and administrative - related party	180,000	85,000
Stock Based Compensation Expense Officers [Member]
General and administrative - related party	495,459	1,377,764
Office Rent and Expenses [Member]
General and administrative - related party	$ 15,602	$ 25,737

RELATED PARTY TRANSACTIONS (D_2

RELATED PARTY TRANSACTIONS (Details 1) - USD ($)	Sep. 30, 2024	Sep. 30, 2023
RELATED PARTY TRANSACTIONS
Related party liabilities	$ 443,093	$ 772,532
Fees, bonus, and accounts payable, former CTO [Member]
RELATED PARTY TRANSACTIONS
Related party liabilities	30,000	30,000
Accounts payable, President and COO [Member]
RELATED PARTY TRANSACTIONS
Related party liabilities	26,418	0
Bonus CEO [Member]
RELATED PARTY TRANSACTIONS
Related party liabilities	68,040	70,000
Management fees, Chief Executive Officer (CEO) [Member]
RELATED PARTY TRANSACTIONS
Related party liabilities	110,000	110,000
Stock to be issued President and COO [Member]
RELATED PARTY TRANSACTIONS
Related party liabilities	$ 208,635	$ 562,532

RELATED PARTY TRANSACTIONS (D_3

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)					1 Months Ended	12 Months Ended
	May 08, 2024	Sep. 07, 2023	Jul. 10, 2023	May 11, 2023	Oct. 26, 2021	Sep. 30, 2024	Sep. 30, 2023	Oct. 25, 2020
Amortizatization expences						$ 624,458
Purchase of common stock shares		5,000,000
Common stock price per share		$ 0.041
General and administrative - related party						871,061	$ 1,843,501
Stock-based compensation						1,967,989	3,136,341
Monthly rent for office space						2,575
Annual lease payment								$ 50,000
Related party liabilities						443,093	772,532
Warrant Member
Stock-based compensation						213,181	142,121
Chief Administrative Officer [Member]
Monthly fee						20,000
Office Rent and Expenses [Member]
General and administrative - related party						15,602	25,737
Consulting Executive Officer Agreement [Member]
Monthly fee						$ 10,000
Issuance of common stock shares per month	3,000,000					250,000
Purchase of common stock shares				5,000,000		10,000,000
Common stock price per share				$ 0.04		$ 0.02
Expiry date						Jul. 01, 2025
Warrant to purchase of common stock						250,000
Warrant exercise price						$ 1
Stock-based compensation							200,000
Consulting Executive Officer Agreement [Member] | July 10, 2023 [Member]
Purchase of common stock shares			15,000,000
Common stock price per share			$ 0.0406
Stock-based compensation							609,000
Consulting Executive Officer Agreement [Member] | September 7, 2023 [Member]
Monthly fee						$ 15,000
Purchase of common stock shares		5,000,000
Common stock price per share		$ 0.041
Stock-based compensation							205,000
Black Scholes Option 1 [Member]
Amortizatization expences						624,458
Stock-based compensation						208,153	138,768
Black Scholes Option [Member]
Amortizatization expences						639,543
Stock-based compensation						74,125	$ 82,875
Accounts Payable CTO [Member]
Operating lease payments					$ 3,500
Accounts Payable CTO [Member] | Maximum [Member]
Monthly fee						$ 15,000

NOTE PAYABLE (Details Narrative

NOTE PAYABLE (Details Narrative) - USD ($)	Jan. 10, 2024	Jan. 10, 2023
NOTE PAYABLE
Interest rate	8%	8%
Proceeds from debt or equity, amount		$ 1,000,000
Debt instrument face amount		$ 40,000
Debt instrument collateral, description	On August 12, 2024, the Company has agreed to transfer 45,000 shares of RM stock to RM (the lender) for satisfaction of the note and accrued and unpaid interest
Collateral Pledged Shares	45,000
Maturity date		Jan. 10, 2024
Debt instrument principal balance	$ 43,200

CONVERTIBLE NOTES PAYABLE (Deta

CONVERTIBLE NOTES PAYABLE (Details) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
CONVERTIBLE NOTES PAYABLE
Beginning balance, face value	$ 1,215,000	$ 0
Convertible notes issued	2,593,450	1,215,000
Convertible notes converted	(2,369,500)	0
Convertible note discount amount	0	(48,212)
Ending balance	$ 1,438,950	$ 1,166,788

CONVERTIBLE NOTES PAYABLE (De_2

CONVERTIBLE NOTES PAYABLE (Details 1) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Convertible promissory note	$ 1,438,950	$ 1,166,788
Convertible Debt [Member]
Convertible promissory note	1,438,950	1,166,788
Convertible Debt [Member] | December 31, 2024 [Member]
Convertible promissory note	$ 160,000	111,788
Interest rate	18%
Convertible Debt [Member] | June 2023 [Member]
Convertible promissory note	$ 0	550,000
Interest rate	18%
Convertible Debt [Member] | September 2023 [Member]
Convertible promissory note	$ 0	505,000
Interest rate	18%
Convertible Debt [Member] | December 28 2024 [Member]
Convertible promissory note	$ 40,000	0
Interest rate	18%
Convertible Debt [Member] | March 31 2025 [Member]
Convertible promissory note	$ 350,000	0
Interest rate	18%
Convertible Debt [Member] | June 30 2025 [Member]
Convertible promissory note	$ 763,950	0
Interest rate	18%
Convertible Debt [Member] | September 30 2025 [Member]
Convertible promissory note	$ 125,000	$ 0
Interest rate	18%

CONVERTIBLE NOTES PAYABLE (De_3

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)		3 Months Ended						12 Months Ended
	Jan. 10, 2023	Jun. 30, 2024	Mar. 31, 2024	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Feb. 29, 2024	Dec. 06, 2023
Convertible note issued								$ 2,593,450	$ 1,215,000
Amortization of debt discount								0	(48,212)
Convertible promissory note					$ 1,166,788			$ 1,438,950	$ 1,166,788
Maturity date	Jan. 10, 2024
Issuance of common stock shares					426,831,170			469,877,826	426,831,170		6,000,000
Aggregated principal amount					$ 505,000			$ 0	$ 505,000
Convertible Note [Member]
Convertible promissory note							$ 100,000			$ 60,000
March 2024 [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights			$ 0.025
Stock price			$ 2
Convertible promissory note			$ 517,500					350,000
Interest rate			18%
Maturity date			Mar. 31, 2025
Exercise price of stock			$ 2
Amount due to related party								$ 167,500
Issuance of common stock shares								83,750
Conversion price of RM Stock			$ 2.50
March 2024 [Member] | RM Stock [Member]
Convertible promissory note			$ 250,000
March 2023 [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.025
Stock price							$ 1
Convertible promissory note							$ 160,000
Interest rate							18%
Maturity date							Jul. 01, 2024
Exercise price of stock							$ 1
March 2023 [Member] | RM stock Note One [Member]
Convertible note issued							$ 50,000
Warrant to purchase							2,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.025
Additional warrant to purchase							100,000
Stock price							$ 1
Expiration date							July 1, 2025
Amortization of debt discount								$ 23,549	19,867
March 2023 [Member] | RM Stock Another Note 2 [Member]
Convertible note issued							$ 50,000
Warrant to purchase							2,000,000
Class of Warrant or Right, Exercise Price of Warrants or Rights							$ 0.025
Additional warrant to purchase							100,000
Stock price							$ 1
Expiration date							July 1, 2025
Amortization of debt discount								24,663	18,922
Debt discounts							$ 43,416	43,585
Convertible notes payable, net of discount					$ 160,000			160,000	$ 160,000
June 2023 [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights						$ 0.02
Stock price						$ 1
Maturity date						Jun. 30, 2024
Issuance of common stock shares						550,000
Conversion price of RM Stock						$ 0.025
Aggregated principal amount						$ 550,000
Convertible promissory note						$ 500,000
Interest rate						18%
Convertible exercise price						$ 1
Conversion of convertible shares						$ 50,000
December 2023 [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights				$ 0.025
Stock price				$ 1
Convertible promissory note				$ 40,000				$ 40,000
Interest rate				18%
Maturity date				Dec. 31, 2024
Exercise price of stock				$ 1
June 2024 [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights		$ 0.025
Convertible promissory note		$ 1,910,950
Interest rate		18%
Maturity date		Jun. 30, 2025
Exercise price of stock		$ 2
Issuance of common stock shares		573,500
Amount due to related party		$ 1,147,000
Balance of convertible note		763,950
June 2024 [Member] | RM Stock [Member]
Convertible promissory note		$ 85,000
September 30, 2024 [Member]
Class of Warrant or Right, Exercise Price of Warrants or Rights					$ 0.025			$ 0.025	$ 0.025
Stock price					$ 1			$ 2
Convertible promissory note					$ 505,000			$ 125,000	$ 505,000
Interest rate					18%			18%
Maturity date					Sep. 30, 2024			Sep. 30, 2025
Exercise price of stock					$ 1			$ 2	$ 1
Issuance of common stock shares					505,000				505,000
Balance of convertible note								$ 125,000
Aggregated principal amount					$ 550,000			$ 0	$ 550,000

CAPITAL STOCK (Details)

CAPITAL STOCK (Details) - Stock Options [Member] - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Outstanding, beginning balance	20,000,000	0
Issued		20,000,000
Outstanding, ending balance	20,000,000	20,000,000
Number of options outstanding exercisable	15,000,000	5,000,000
Weighted average exercise price, beginning balance	$ 0.02	$ 0
Weighted average exercise price, issued		0.02
Weighted average exercise price, ending balance	0.02	0.02
Weighted average exercise price, exercisable	$ 0.02	$ 0.02
Weighted average remaining term in years, issued		2 years 4 months 13 days
Weighted average remaining term in years, outstanding	9 months	1 year 9 months

CAPITAL STOCK (Details 1)

CAPITAL STOCK (Details 1) - Warrants Member - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Outstanding, beginning balance	8,000,000	0
Number of share warrants issued		8,000,000
Expired or cancelled or forfeited	(4,000,000)
Outstanding, ending balance	4,000,000	8,000,000
Weighted average exercise price, beginning balance	$ 0.0225	$ 0
Weighted average exercise price, Expired or cancelled or forfeited		0.0225
Weighted average exercise price, warrants issued		0.0225
Weighted average exercise price, ending balance	$ 0.0225	$ 0.0225
Weighted average remaining term in years, Issued		1 year 10 months 9 days
Weighted average remaining term in years, outstanding and exercisable	9 months	1 year 3 months

CAPITAL STOCK (Details 2)

CAPITAL STOCK (Details 2) - Warrants to purchase RM Stock Member - $ / shares	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Outstanding, beginning balance	900,000	0
Number of share warrants issued	50,000	900,000
Outstanding, ending balance	950,000	900,000
Weighted average exercise price, beginning balance	$ 1	$ 0
Weighted average exercise price, warrants issued	1.50	1
Weighted average exercise price, ending balance	$ 1.03	$ 1
Weighted average remaining term in years, issued	1 year	2 years 1 month 24 days
Weighted average remaining term in years, outstanding and exercisable	8 months 26 days	1 year 6 months 10 days

CAPITAL STOCK (Details Narrativ

CAPITAL STOCK (Details Narrative) - USD ($)						1 Months Ended		12 Months Ended
	Mar. 03, 2023	Mar. 02, 2023	Feb. 10, 2023	Feb. 08, 2023	Aug. 04, 2022	Mar. 03, 2023	Feb. 02, 2023	Sep. 30, 2024	Sep. 30, 2023	May 16, 2024	Apr. 01, 2024	Dec. 06, 2023	May 11, 2023	Feb. 01, 2023	Dec. 05, 2022
Common stock shares, authorized								600,000,000	600,000,000
Common stock shares, issued								469,877,826	426,831,170			6,000,000
Common stock share, outstanding								469,877,826	426,831,170
Common stock issued for services, amount								$ 794,350	$ 2,175,819
Stock-based compensation								$ 1,967,989	$ 3,136,341
Preferred stock, shares authorized								100,000,000	100,000,000
Preferred stock, par value								$ 0.001	$ 0.001
February 1, 2023 [Member]
Stock-based compensation								$ 208,153	$ 138,768
Consulting Agreement [Member]
Expiration date	July 1, 2025							July 1, 2025
Common stock shares, issued	2,000,000					2,000,000		2,500,000	500,000	2,500,000		6,000,000	5,000,000	250,000	500,000
Exercise price	$ 0.02					$ 0.02				$ 0.03				$ 0.02
Stock-based compensation	$ 169,200				$ 150,150			$ 74,125	$ 82,875
Stock Options [Member]
Weighted average remaining term in years, issued								2 years 4 months 13 days
Unrecognized stock compensation expense								$ 284,241
Share-based payment arrangement, nonvested award, cost not yet recognized, share								5,000,000
Share-based compensation arrangement by share-based payment award						10,000,000	10,000,000
Stock compensation expense								$ 187,354	262,297
Share-based compensation arrangement by share-based payment award, non-option equity instruments, exercised						$ 0.02	$ 0.02
Share-based compensation arrangement by share-based payment award, non-option equity instruments, vested						2,500,000
Vesting percentage						25%	25%
Stock option value						$ 449,651	$ 639,543
Warrants Member | Consulting Agreement [Member]
Exercise price	$ 1					$ 1
Fair value of warrant	$ 624,556					$ 624,556
Warrant to purchase shares of RM stock based on black scholes option pricing model, share	250,000					250,000
Warrants Member | Consulting Agreement [Member] | April 1, 2024
Exercise price											$ 1.50
General and Administrative expenses- related party								119,348
Fair value of warrant											$ 119,348
Warrant to purchase shares of RM stock based on black scholes option pricing model, share											50,000
Warrant [Member]
Expiration date		July 1, 2025	July 1, 2025	July 1, 2025		July 1, 2025	July 1, 2025
Exercise price	$ 0.025	$ 0.02	$ 0.025	$ 0.02		$ 0.025	$ 1
Warrant to purchase, amount		$ 5,000		$ 5,000
Stock-based compensation								213,181	142,121
Fair value of warrant	$ 89,916		$ 79,914			$ 89,916	$ 624,458
Warrant to purchase shares of RM stock, shares	100,000	100,000	100,000	100,000		100,000
Warant exercise price RM stock	$ 1	$ 1	$ 1	$ 1		$ 1
Warrant to purchase share	2,000,000	2,000,000	2,000,000	2,000,000		2,000,000	250,000
Warrant to purchase shares of RM Stock based on Black scholes option pricing Model, value			$ 249,811
Discount amount based on allocations	$ 43,585		$ 43,416			$ 43,585
Interest expense								23,549	19,867
Warrant [Member] | March 3, 2023 [Member]
Stock-based compensation								260,232	364,324
Interest expense								$ 24,662	$ 18,923
Series C Preferred Stock [Member]
Preferred stock, shares authorized								12,000,000	12,000,000
Preferred stock, par value								$ 0.001	$ 0.001
Designated preferred shares								12,000,000
Preferred stock shares issued								600,000	600,000
Preferred stock shares outstanding								600,000	600,000
Series D Preferred Stock [Member]
Preferred stock, shares authorized								10,000,000	10,000,000
Preferred stock, par value								$ 0.001	$ 0.001
Preferred stock shares issued								50,000	50,000
Preferred stock shares outstanding								50,000	50,000
Series E Preferred Stock [Member]
Preferred stock, shares authorized								13,650,000	13,650,000
Preferred stock, par value								$ 0.001	$ 0.001
Preferred stock shares issued								0	0
Preferred stock shares outstanding								0	0
Series F Preferred Stock [Member]
Common stock issued for services, shares									41,575,000
Stock-based consulting expense									$ 20,171
Share price								$ 0.20
Exercise price								$ 1.50
Common stock issued for services, amount									$ 2,175,819
Common stock issued for payment of account payable share									1,440,750
Common stock issued for payment of account payable									$ 67,440
Common stock issued in settlement of stock Payable									$ 54,750
Preferred stock, shares authorized								10,000,000	10,000,000
Accounts payable related parties								$ 47,269
Risk free interest rate								5.03%
Volatility								145%
Preferred stock, par value								$ 0.001	$ 0.001
Designated preferred shares								59,270,000
Preferred stock shares issued								0	0
Preferred stock shares outstanding								0	0
Common Stock [Member]
Common stock shares, authorized								600,000,000	600,000,000
Common stock shares, par value								$ 0.001	$ 0.001
Common stock shares, issued								469,877,826	426,831,170
Common stock share, outstanding								469,877,826	426,831,170
Common Stocks [Member] | Subscription Agreement [Member]
Expiration date		July 1, 2024	July 1, 2025
Common stock issued for services, shares								4,000,000
Share price								$ 0.02
Exercise price								$ 0.02
Warrant to purchase, shares								4,000,000
Warrant to purchase, amount								$ 10,000
Warrants sold								$ 10,000
Warrant to purchase shares of common xtock								200,000
Warant exercise price RM stock								$ 1
Common Stocks [Member] | January 18, 2024 [Member]
Common stock issued for services, shares								5,000,000
Stock-based consulting expense								$ 78,000
Common stock issued for services, amount								$ 104,000
Common Stocks [Member] | December 14, 2023 [Member]
Common stock issued for services, shares								6,000,000
Common stock issued for services, amount								$ 169,200
Common Stocks [Member] | April 24 2024 One [Member]
Common stock issued for payment of account payable share								3,000,000
Common stock issued for payment of account payable								$ 108,250
Common stock issued settlement Of stock payable								90,000
Gain on debt extinguishment								$ 18,250
Common Stocks [Member] | April 24 2024 Two [Member]
Common stock issued for services, shares								3,000,000
Stock-based consulting expense								$ 46,800
Common stock issued for services, amount								$ 62,400
Common Stocks [Member] | April 24 2024 [Member]
Common stock issued for payment of account payable share								2,285,804
Common stock issued for payment of account payable								$ 56,584
Common stock issued settlement Of stock payable								66,407
Gain on debt extinguishment								$ 9,823
Common Stocks [Member] | September 6, 2024 [Member]
Common stock issued for payment of account payable share								2,559,558
Common stock issued for payment of account payable amount								$ 63,989
Common stock issued settlement Of stock payable								73,715
Gain on debt extinguishment								$ 9,726
Common Stocks Share[Member] | April 24 2024 Three [Member]
Common stock issued for services, shares								3,000,000
Stock-based consulting expense								$ 82,500
Common stock issued for services, amount								$ 82,500
Common Stocks Share[Member] | April 24 2024 Four [Member]
Common stock issued for services, shares								1,500,000
Stock-based consulting expense								$ 16,875
Common stock issued for services, amount								$ 33,750
Common Stocks Share[Member] | April 24 2024 Five [Member]
Common stock issued for services, shares								2,500,000
Stock-based consulting expense								$ 28,125
Common stock issued for services, amount								$ 56,250
Common Stocks Share[Member] | April 24 2024 Six [Member]
Common stock issued for services, shares								2,500,000
Stock-based consulting expense								$ 34,375
Common stock issued for services, amount								$ 68,750
Common Stocks Share[Member] | May 16, 2024 [Member]
Common stock issued for services, shares								2,500,000
Common stock issued for services, amount								$ 75,000
Common Stocks Share[Member] | May 16 2024 One [Member]
Common stock issued for services, shares								5,000,000
Stock-based consulting expense								$ 142,500
Common stock issued for services, amount								$ 142,500
Common Stocks Share[Member] | May 23 2024 [Member]
Common stock issued for payment of account payable share								85,883
Common stock issued for payment of account payable amount								$ 1,718
Common stock issued settlement Of stock payable								2,405
Gain on debt extinguishment								$ 687
Common Stocks Share[Member] | January 12 2024 [Member]
Common stock issued for payment of account payable share								2,227,661
Common stock issued for payment of account payable amount								$ 55,124
Common stock issued settlement Of stock payable								46,336
Gain on debt extinguishment								$ 8,788
Common Stocks Share[Member] | November 30 2023 [Member]
Common stock issued for payment of account payable share								1,887,750
Common stock issued for payment of account payable amount								$ 46,826
Common stock issued settlement Of stock payable								50,781
Gain on debt extinguishment								$ 3,955

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)							1 Months Ended				12 Months Ended
	May 08, 2024	May 07, 2024	Apr. 02, 2024	Sep. 07, 2023	Mar. 03, 2023	Aug. 04, 2022	May 16, 2024	Apr. 23, 2024	Feb. 14, 2023	Jul. 19, 2022	Sep. 30, 2024	Sep. 30, 2023	May 09, 2024	Apr. 01, 2024	Dec. 06, 2023	Jul. 10, 2023	May 11, 2023	Apr. 01, 2023	Feb. 01, 2023	Dec. 05, 2022	Dec. 02, 2022	Nov. 16, 2022
Common stock shares, issued											469,877,826	426,831,170			6,000,000
Purchase of common stock shares				5,000,000
Stock-based compensation expense											$ 187,354	$ 262,297
Common stock price per share				$ 0.041
Stock-based compensation											1,967,989	3,136,341
Stock-based compensation expense-related party				$ 205,000							260,232	364,324
General and administrative - related party											871,061	$ 1,843,501
Amortizatization expences											$ 624,458
Purchase of warrant value					$ 449,651
Common stock to be issued		3,000,000
Class A [Member]
Common stock shares, issued											3,301,233	5,100,000
Voting stock percentage											1.57%	2.49%
Consulting Executive Officer Agreement [Member]
General and administrative - related party											$ 208,153	$ 138,768
Investor Awareness Advisory Services Agreement [Member]
Common stock shares, issued										500,000
Stock-based compensation											$ 75,000	$ 50,000
Investor awareness advisory services, expense amount										$ 10,000
Exercise price					$ 1														$ 1
Expiry date					Jul. 01, 2025
Consulting Agreement [Member]
Common stock shares, issued					2,000,000		2,500,000				2,500,000	500,000			6,000,000		5,000,000		250,000	500,000
Common stock price per share					$ 0.0282
Stock-based compensation					$ 169,200	$ 150,150					$ 74,125	$ 82,875
Monthly fee											10,000								$ 10,000	$ 5,000
Issuance of restricted common stock shares						1,300,000						1,000,000							10,000,000	1,200,000	1,000,000	1,000,000
Stock-based compensation expense-related party					$ 200,000						$ 200,000	$ 609,000
Initial shares issued					10,000,000														250,000
Exercise price					$ 0.02		$ 0.03												$ 0.02
Voting stock percentage					25%														25%
Share issued to seacond tranch						975,000
Issuance of common stock shares per month											250,000
Amortizatization expences											$ 639,543
Warrant to purchase					624,556
Warrant issued					250,000
Share price																	$ 0.04
Expiry date					July 1, 2025						July 1, 2025
Number of share valued based on price of common stock					$ 80,000
Monthly fees increased decreased											$ 15,000
Consulting Agreement [Member] | COO [Member]
Common stock price per share																$ 0.0406
Stock-based compensation											213,181	142,121
Share price																	$ 0.04
Share issued																	5,000,000
Share-based payment arrangement, nonvested award, cost not yet recognized, share																15,000,000
Agreement for Board of Advisor Services [Member]
Common stock issued for settlement of accrued interest	1,500,000							3,000,000
Common stock shares, issued	2,500,000							5,000,000					2,500,000	2,500,000
Further share issued														2,500,000
General and administrative - related party											68,749
Warrant to purchase, value														$ 119,348
Common stock to be issued, value			$ 137,500					$ 67,500			$ 112,500
Agreement for Board of Advisor Services [Member] | Class A [Member]
Common stock price per share														$ 1.50
Warrant to purchase														50,000
November 16, 2022 [Member]
Stock-based compensation												86,000
August 8, 2022 [Member]
Common stock to be issued											325,000
December 2, 2022 [Member]
Issuance of restricted common stock shares																					1,000,000
Stock-based compensation												100,000
April 1, 2023 [Member] | Consulting Agreement [Member]
Stock-based compensation											$ 6,012	6,012
Issuance of restricted common stock shares																		250,000
Shares vest in equal amounts																		20,833
October 1, 2023 [Member] | Marketing Services Agreement [Member]
Common stock price per share											$ 0.0269
General and administrative - related party											$ 80,700
Common stock to be issued											3,000,000
Common stock to be issued, value											$ 80,700
January 1, 2024 [Member] | Marketing Services Agreement [Member]
General and administrative - related party											$ 46,800
Common stock to be issued	30,000,000										3,000,000
Common stock to be issued, value											$ 62,400
January 2, 2024 [Member] | Marketing Services Agreement [Member]
General and administrative - related party											$ 78,003
Common stock to be issued											5,000,000
Common stock to be issued, value											$ 104,000
March 19, 2024 [Member] | Marketing Services Agreement [Member]
General and administrative - related party											$ 6,500
Common stock to be issued											3,000,000
Common stock to be issued, value											$ 78,000
December 5, 2022 [Member] | Consulting Agreement [Member]
Stock-based compensation											55,393	$ 120,000
Restricted share issued									500,000
May 1, 2023 [Member] | Marketing Services Agreement [Member]
General and administrative - related party											166,250
Amortizatization expences											$ 23,750
Description for the agreement of advisor services							The Company valued the 5,000,000 shares at $142,500 ($0.0285 per share) and the Company is amortizing the expense related to the 2,000,000 shares (valued at $57,000) over the term of the contract
Common stock to be issued							5,000,000				7,000,000
Additional Common stock to be issued							2,000,000
Common stock to be issued, value											$ 142,500
April 23, 2024 [Member] | Agreement for Board of Advisor Services [Member]
General and administrative - related party											33,750
April 23, 2024 One [Member] | Agreement for Board of Advisor Services [Member]
General and administrative - related party											$ 56,250

LICENSE AGREEMENT (Details Narr

LICENSE AGREEMENT (Details Narrative) - USD ($)		12 Months Ended
	Aug. 09, 2022	Sep. 30, 2024	Dec. 06, 2023	Sep. 30, 2023	May 15, 2023	Jun. 22, 2022
Common Stock shares outstanding		469,877,826		426,831,170
Common stock shares, issued		469,877,826	6,000,000	426,831,170
Convertible promissory note		$ 1,438,950		$ 1,166,788
Common Stock Class B [Member] | Mr Collins [Member]
Common stock shares, issued						1,600,000
Cancellation of common stock					1,600,000
Total number of share exchanged					200,000
Common Stock Class B [Member] | Mr Chermak [Member]
Common stock shares, issued						1,000,000
Common Stock Class B [Member] | Mr Ansari [Member]
Common stock shares, issued						1,000,000
Intellectual Property License Agreement [Member] | Common Stock Class A [Member]
Common stock shares, issued	5,100,000	10,459,199		8,257,714
Royalty percentage of net sale	5%
Reticulate Micro, Inc. [Member]
Stock Issued		1,798,767
Convertible promissory note		$ 45,000
Accrued interest		84,888
Convertible notes and accrued interest		$ 2,499,388
Common Stock Class B [Member]
Common Stock shares outstanding		2,000,000		2,000,000
Common Stock voting shares		100		100
Class A [Member]
Common stock shares, issued		3,301,233		5,100,000
Voting stock percentage		1.57%		2.49%

INCOME TAXES (Details )

INCOME TAXES (Details ) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Pre-tax loss	$ (4,264,412)	$ (4,728,473)
U.S. statutory [Memner]
Pre-tax loss	$ (4,264,412)	$ (4,728,473)
U.S. federal corporate income tax rate	21%	21%
Expected U.S. income tax credit	$ (895,527)	$ (992,979)
Permanent differences	423,402	658,631
Change of valuation allowance	472,125	334,348
Effective tax expense	$ 0	$ 0

INCOME TAXES (Details 1)

INCOME TAXES (Details 1) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
INCOME TAXES
Net operating losses carried forward	$ 2,445,350	$ 1,973,226
Less: Valuation allowance	(2,445,350)	(1,973,226)
Net deferred tax assets	$ 0	$ 0

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	Sep. 30, 2024	Sep. 30, 2023
INCOME TAXES
Net operating loss carryforwards	$ 11,645,000	$ 9,396,000

DEFERRED REVENUE (Details Narra

DEFERRED REVENUE (Details Narrative) - USD ($)	12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
DEFERRED REVENUE
Revenue from Contracts with Customers	$ 4,995	$ 32,470
Deferred revenues	2,914	2,411
Revenues	$ 4,492	$ 30,059